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ABSTRACT
The boronic acid functional group is known to bind compounds with the diol group
tightly and reversibly in aqueous environment and has been used as a recognition moiety for the
design of carbohydrate sensors. The first chapter of the dissertation studies the synthesis and
substitution effect on the affinity and selectivity of a known boronic acid-based glucose sensor.
In such a sensor design effort, the availability of a signaling event, whether it is fluorescence or
UV, is crucial. The second chapter studies the detailed mechanism on how a well-known
fluorescent boronic acid compound changes fluorescent properties upon binding.

A new

mechanism has been established which corrected a decade old mistake. In the third chapter, a
series of boronic acid-based sensors were designed and synthesized for sialic acid, which is part
of tetrasaccharide found on many cell surface carbohydrates. Such sialic acid sensors could be
very useful for the development of new type of anti-influenza therapy. The fourth is on the
design and synthesis novel and selective inhibitors for phosphodiesterase 4 (PDE4), which are
potential anti-asthma agents.
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Chapter 1. Substituent effect on anthracene-based bisboronic acid
glucose sensors
Abstract: Anthracene-based boronic acid has been studied as potential sensors for
glucose detection. Aimed at understanding the substituent effect, various functional
groups were introduced, such as the cyano, nitro, and fluoro group on the boronic acid
moiety of the glucose sensor. Fluorescent binding studies indicated that the cyanosubstituted sensor has the highest affinity (Keq 2540 M-1) for glucose, but the lowest
selectivity (3-fold over fructose); the fluoro-substituted compound shows the lowest
affinity (630 M-1) and a modest selectivity (15-fold over fructose); and the unsubstituted
one shows the highest selectivity over fructose (43-fold) and a modest affinity (1472 M1

).

1

1.1.

Introduction

Carbohydrates are considered critical to various biological processes.1-5 The most
prominent among them is glucose which is a critical energy supplier to cells, and its
elevated concentration is the primary symptom of diabetes.6 Sensors for the biologically
important carbohydrates have the potential to be used as diagnostics, new imaging agents,
as well as therapeutics.7-9 Generally, selective sensors consists of three components: a)
proper functional groups that afford strong intermolecular interactions (boronic acid), b) a
‘reporter’ event/moiety (stars) that allows the binding event to be recognized, and c) the
appropriate three-dimensional scaffold that allow for necessary complementarily in terms
of size, shape, and functional group orientation (bridge) as shown in Figure 1.1. There is
especially strong interest in developing boronic acid-based sensors10-16 because of the
ability of the boronic acid group to form reversible and tight complexes with diolcontaining compounds.10, 13, 14, 17-25 Boronic acids have been used to develop fluorescent
sensors,11, 13, 14, 21, 22, 26-28 color sensors,8, 11-13, 15, 16, 26, 29-36 sensors for cell recognition
based on surface carbohydrate biomarkers,22 carbohydrate transporters,37-42 and
chromatographic stationary materials.43-48

OH
HO B

Figure 1.1.

OH
B
OH

Three components of a "selective" sensor
2

1.1.1. Interaction between boronic acid and carbohydrate containing diols
Boronic acids covalently react with 1,2 or 1,3 diols to form reversible five- or sixmembered cyclic esters in aqueous media. The cis diols of saccharides normally form
stronger cyclic esters than the trans or acyclic diols. Boronic acids are Lewis acids and
can react with water to form the neutral trigonal form (1) to the anionic tetrahedral form
(2) (Scheme 1). The same is true for the diol – boronic complex or the boronic ester (3).

B(OH)2

HO
OH
B
OH

H+

K a-acid

(1)
R1

H2O

(2)

R1

R2

R2
HO

HO

OH

OH
Keq-tet

Keq-trig

2 H2O

2 H2O
H2O
R1
O
B

R2
O

K a-ester

(3)

H+

R1
O
HO
B

R2
O

(4)

Scheme 1.1. Binding process between phenylboronic acid and a diol

1.1.2. Design of fluorescent boronic acid sensor
As mentioned above, a selective sensor requires proper functional groups that afford
strong intermolecular interactions and a ‘reporter’ event/moiety that allows the binding
3

event to be recognized. The boronic acid moiety fulfills the requirement of strong
intermolecular interaction needed for the sensor design. It is known that the monoboronic
acids have certain intrinsic preference for various carbohydrates, the design of selective
sensors for a particular sugar often relies on the introduction of additional functional
group interactions, such as a second boronic acid unit, with a proper scaffold to afford
selectivity.22 Such an approach has been successfully used in various examples.10, 11, 15, 32,
49

Modulation of the affinity of a monoboronic acid for diols can be achieved through the

introduction of various substituents on an arylboronic acid.

Generally speaking,

arylboronic acids with lower pKa values tend to have higher affinities for diols, although
one also needs to consider the pH of the solution and other factors.19 For example, 2fluoro-5-nitrophenylboronic acid has a pKa of about 6.0, which is 2.8 pKa units lower
than that of phenylboronic acid. Consequently, the binding constant between glucose and
2-fluoro-5-nitrophenylboronic acid at physiological pH is about 10-fold higher than that
of phenylboronic acid.19

A fluorophore fulfills the signaling event for the binding

process of sensor. A fluorophore that can change fluorescence upon binding to a
saccharide is an ideal for fluorescent sensor design. One way to design a fluorescent
sensor is through the modulation of an excited state photoelectron transfer (PET) process
that is responsible for the quenching of fluorescence.
The first fluorescence PET sensors for saccharides, the anthrylboronic acids (5 and
6), showed significant fluorescence intensity changes upon binding with saccharide.13
The fluorescence intensity change was due to the change in the hybridization state of the
ester, which has lower pKa than the boronic acid (pKa about 8.8). Specifically, the

4

boronic acid should exist mostly in the neutral trigonal state at the physiological pH and
at such a state PET to the open shell of the boron can happen in the excited state leading
to fluorescence quenching. However, upon ester formation, the boron functionality would
exist in the anionic tetrahedral because of a decreased pKa and such a hybridization
change abolishes the excited PET and therefore removes fluorescence quenching
mechanism.
B(OH)2
B(OH)2

5

6

Figure 1.2. First fluorescence PET sensor developed

A second PET system was developed by Shinkai, where the amino group was
positioned in a 1,5- relationship with the boronic acid. Such an arrangement promoted
dative B-N bond formation.50 It was proposed for the anthracene system that the
anthracene fluorescence can be quenched by the lone pair electrons of the amino group
through excited state photoelectron transfer (PET). It was further proposed that the B-N
bond strengthens upon sugar binding, which “ties up” the lone pair electrons, abolishes
the PET, and results in a fluorescence intensity increase. Although the mechanism
proposed has proven to be incorrect (this will be discussed in detail in Chapter 2), indeed,
upon sugar binding, 7 (Scheme 1.2) shows much higher fluorescent intensity. The
positioning of an amino group also lowers the pKa of the boronic acid, and increases its
5

binding affinity for diols. Therefore, 7 showed much higher binding affinity to glucose
and fructose compared with phenyl boronic acid. Shinkai et al also developed a similar
anthracene system with bisboronic acid unit (9).10 Compound 9 was selective for glucose
over fructose.
R2
(HO)2B

R1

..

HO

N

R2

R1

OH

O OH
B
O
N
H

hv'

hv

hv

hv

(7)

(8)

Boronic acid
Weakly fluorescent

Boronate ester
Strongly fluorescent

Scheme 1.2. Mechanism of an anthracene-based photoinduced electron transfer system

(HO)2B
N

N
(HO)2B

9

Figure 1.3. First bisboronic acid sensor developed by Shinkai

6

Our group has designed a highly selective anthracene-based boronic acid sensor for
glucose (10a, Figure 1.4).22 The sensor design used the Shinkai fluorescent reporter10
which showed an increase in fluorescence intensity upon binding with a diol due to
protonation of the amine nitrogen upon binding, the details of which will be discussed in
Chapter 2.51 Compound 10a showed about 43-fold selectivity for glucose over fructose
and 49-fold selectivity over galactose.

N

B(OH)2

(OH)2B

N

N

N

B(OH)2

N
O

O

10b

10a

Figure 1.4. Dianthraceneboronic acid (10a) and anthracenemonoboronic acid (10b)

1.2. Project Objective
In this study, we are interested in studying the effect of electron withdrawing
groups on the binding affinity between the bisboronic acid and various saccharides. We
designed and synthesized analogs of 10a and 10b with different electron-withdrawing
7

substitutents on the arylboronic acid portion of the bisboronic acid sensor aimed at
achieving a better understanding of the substituents effect. Specifically, there are two
questions we wish to answer: (1) will the affinity-enhancing effect of electron
withdrawing groups such as fluoro, nitro, and cyano substituents be translated into
enhanced affinity of the bisboronic acid sensors for saccharide and (2) how will such
electron-withdrawing groups affect the selectivity of the parent boronic acid sensors 10a
and 10b. With that in mind three analogs of 10a22 and 10b10 with the cyano, nitro, and
fluoro functional groups para position to the boronic acid were synthesized.

Their

binding constants with various sugars were determined.
1.3.

Synthesis
Well established routes were used to synthesis the building blocks and final

bisboronic acids compounds.22,

36, 52

Figure 1.5 shows the target anthracene based

bisboronic and monoboronic acids compounds that were synthesized.

8

X

N

X

B(OH)2

(OH)2B

N

X

N

N

B(OH)2

N
O

X = 25 = CN
26 = NO2
27 = F

O

X = 29 = CN
30 = NO2
31 = F

Figure 1.5. Synthesized target bisboronic and monoboronic acids compounds

9

1.3.1. Synthesis route to the common building block, bisanthracene amide
O

O
Me3SI/NaH/DMSO

LiBr/CH3CN
O

O
11

12
92%
NH

CHO
1) MeNH2/THF-MeOH
2) NaBH4

OH
13
94%
N Boc

(Boc)2O/MeOH/TEA
OH
14
95%
N Boc
1) MeNH2/THF-MeOH

Py.SO3/TEA/DMSO

2) NaBH4
OH
15

O H
16

94%

99%

N Boc

N Boc Boc N
HO
O

NH
17
74%

OH
O EDCI/ HOBT/ DMAP/DCM
N

N
O

O
18
59%

Scheme 1.3. Synthesis of intermediate Boc-protected diamides 18
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The synthesis of intermediate 18 took seven steps starting from the commercially
available anthraquinone (11). 11 was first reacted with the trimethyl sulfonium ylide in
dimethyl sulfoxide (DMSO) to give bis(epoxide), which then underwent rearrangement
in the presence of lithium bromide in refluxing acetonitrile to give hydroxyaldehyde (13)
in 94% yield.52 Reductive amination of hydroxyaldehyde with methyl amine in
MeOH/THF and NaBH4 gave secondary amine (14) in 95% yield. The amine was
protected with di-tert-butyldicarbonate in methanol in the presence of triethyl amine
(TEA) to give 15 in 94 % yield. The hydroxyamine (15) was oxidized with pyridine
sulfur trioxide complex in DMSO to give aldehyde (16) in quantitative yield. The
resulting aldehyde underwent reductive amination to give amine (17) in 74% yield. The
coupling reaction between amine (17) and the acid linker in the presence of 1-(2diemthyl-amino propyl)-3-ethylcarbodiimide hydrochloride (EDCI) gave the intermediate
18 in 59 % yield.

1.3.2. Synthesis of para substituted arylboronic esters
To study the effect of electron withdrawing groups on the binding affinity of the
boronic acid for the saccharide, para substituted arylboronic acids were needed. For the
study, three para substituted arylboronic acids were synthesized with cyano, nitro, and
fluoro as electron withdrawing groups. They were then introduced to the intermediate 18
to give the final bisboronic acids. Here only the syntheses of fluoro substituted
arylboronic acid I prepared is reported (Scheme 1.4). The other two substituted aryl
boronic acids (19, 20) were synthesized by Mr. Haibo Li using similar procedures.

11

OH
Br

1) n-BuLi/THF,B(OiPr)3
2) HCl, H2O

F

B OH

HO
HO

Toulene, 125 o C

F
22

21

Br
O
B
O

O
B
O

NBS/AIBN/Toulene

F

F

24

23

Scheme 1.4. Synthesis of 4-fluoro-2- phenylboronic acid (24)

Commercially available bromo-2-methyl-4-fluoro-benzene (21) was
transmetalated with n-butyl lithium and then quenched with trisopropyl borate to give
protected boronic acid which was cleaved during acidic work up to give free boronic acid
(22). Free boronic acid was then protected with neopentyl glycol at 115 °C for the ease of
deprotection at the end of the synthesis. Bromination of 23 in presence of NBS and
AIBN yielded 24 in 68% yield.
The above method for the synthesis of neopentyl protected boronic acid (24) took
three steps whereas a recently developed palladium catalyzed borylation method can be
done in two steps for the same compound (24). Also, the palladium-catalyzed method
can be used for the borylation of substrates that contain functional groups such as cyano,
nitro, amino, hydroxyl, which may not be compatible with organometallic agents such as
n-butyllithium. A separate study was conducted to examine the new bis(neopentyl
glycolato)diboron borylating agent for the palladium catalyzed reaction with substrates
substituted with various functional groups (see section 1.6).
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1.3.3. Synthesis of bisboronic acid and monoboronic acid compounds
X = 19 = CN
20 = NO2
24 = F
Br
N Boc

Boc N

O
B

O

X

N

X

B(OH)2

(HO)2B

N

X
a, b, and c
N

N
O

O
18

N

N
O

O

25 = CN
26 = NO2
27 = F

Scheme 1.5. (a) TFA, DCM; (b) 19, 20, 24, K2CO3, KI, CH3CN; (c) 25 and 26: DCM,
10%NaHCO3, H2O; 27: acetone: H2O (4:1), 1N HCl
Bisboronic acid sensors, compound (25-27) were prepared through alkylation of
intermediate 18 with substituted arylboronic acids. 18 was deprotected using
trifluoroacetic acid (Scheme 1.5) and the free amino group was then reacted with 19, 20,
and 24, respectively, in the presence of K2CO3 in acetonitrile at room temperature to give
the corresponding boronate esters of 25-26. Hydrolysis of the protected boronic acids
under basic conditions in the presence of NaHCO3 gave the free boronic acids 25 and 26;
whereas free boronic acid 27 was obtained under acidic condition in the presence of
HCl.22
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X = 19 = CN
20 = NO2
24 = F
Br
H
N

O
B

O

X

N

B(OH)2

X
a and b
28

29 = CN
30 = NO2
31 = F

Scheme 1.6. (a) 19,20,24, K2CO3, KI, CH3CN; (b) 29 and 30: DCM, 10%NaHCO3,
H2O; 31: acetone: H2O (4:1), 1N HCl

For the synthesis of the monoboronic acids, commercially available anthracen-9ylmethyl-methylamine (28) was reacted with 19, 20, and 24, respectively, in the presence
of K2CO3 in acetonitrile at room temperature to give the corresponding boronate esters
(Scheme 1.6). Hydrolysis of the protected boronic acids was done under the same
conditions as mentioned above to obtain free boronic acids 29-31.22
1.4. Binding Studies
The bisboronic acid and monoboronic acid compounds mentioned above were
expected to show increase in fluorescence upon sugar binding. Furthermore, we were
interested in seeing whether substitutions would change the binding affinity of the
bisboronic acid sensors for diols parallel to that of the monoboronic acid unit. Therefore,
fluorescence experiments were conducted to determine the appropriate binding constants
of 25-27 and 29-31 for various sugars. Since the anthracene-based compounds are fairly
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lipophilic, a 1:1 mixture of methanol and phosphate buffer (pH 7.4) was used as the
solvent with a sensor concentration of about 1 × 10-6 M. The sugars studied include
glucose, fructose, and galactose. As expected, upon sugar addition, all three substituted
glucose sensor analogs (25-27) showed dramatically increased fluorescence intensity.
Figure 1.6 shows two typical sets of fluorescent spectral changes upon sugar addition
using compound 25-27 as examples. It has been proposed in literature that the increase in
fluorescence intensity for such anthracene based boronic acids upon addition of a
saccharide was due to increased B-N bond strength upon sugar binding, which in turn
resulted in reduced fluorescence quenching by photoinduced electron transfer (PET).10
Whereas we have established a different mechanism, the hydrolysis mechanism, for the
increase in the fluorescence intensity upon addition of a sugar. The hydrolysis
mechanism will be discussed in detail in Chapter 2. One would expect these new analogs
to have a similar mechanism in inducing the fluorescent changes upon sugar binding,
although this was not specifically studied.
With the four analogs of dianthraceneboronic acid in hand, the cyano-substituted
compound 25 showed the highest change in fluorescence intensity with a 10-fold increase
upon glucose addition. It also showed the highest binding affinity with an apparent
binding constant (Ka) of 2540 M-1 for glucose (Table 1.1). It is interesting to see that the
nitro-substituted compound (26) showed the lowest fluorescent intensity changes (a
maximum of 2 fold), while having the second highest affinity for glucose (1808 M-1).
The fluoro-substituted analog (27) showed only 4-fold fluorescent intensity change with a
binding constant (630 M-1) that is even smaller than that of the parent compound (10a,
15

1472 M-1).

The binding of these bisboronic acids was compared with that of the

corresponding monoboronic acid analogs (29-31, Table 1.2). It is interesting to note that
the cyanophenylboronic acid compound (25) also showed much higher affinity than
either the nitro (26) or fluoro (27) substituted ones.

Therefore, the results of the

bisboronic acids parallel that of the monoboronic acids in this case.
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Figure 1.6. a) Fluorescence spectra of 25 (1.0 × 10-6 M) with D-glucose (0 mM-10 mM);
b) Fluorescence spectra of 26 (1.0 × 10-6 M) with D-glucose (0 mM-20 mM) at 25 oC in
50% MeOH/0.1 M aqueous phosphate buffer at pH 7.4: λex = 370 nm.
The comparison between the nitro and fluoro-substituted compounds did not yield
the same conclusions. In the monoboronic acid series, the nitro and fluoro-substituted
boronic acids (30 and 31) had similar affinities for both fructose and glucose. On the
other hand, in the bisboronic acid series, the nitro-substituted compound (26) showed a
much higher affinity than the fluoro-substituted one (27). It is also worth noting that the
fluoro-substituted bisboronic acid has an even lower affinity than that of the unsubstituted
control (10a). Such results were somewhat unexpected because fluoro-substitution is
electron-withdrawing. Furthermore, the size of the fluorine atom is small and one would
not expect much perturbation of the conformation of the bisboronic acid compound by
the fluorine atom. Consequently, one would expect 27 to have a higher affinity for
glucose than does 10a.
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The results of the selectivity studies were also somewhat surprising. Sensor 25,
although having the highest affinity for glucose, showed the lowest selectivity with a 3fold preference for glucose over fructose in terms of the binding constants.

This is in

direct contrast to the 43-fold selectivity of 10a for the same pair of sugars.22 Compounds
26 and 27 were somewhere in between. In comparison with the monoboronic acids, it
seems that the cyano-substituted one has a low selectivity problem too, only in this case it
was the selectivity for fructose. Such results could mean that the cyano-substituted
boronic acids have a lower propensity to discriminate among different sugars. However,
the underlying reason for this is not clear.

Table 1.1. Binding Constant (Ka) for compounds 25-27 and 10a with different
saccharides
Compound

Ka (M-1)
glucose

Ka (M-1)
fructose

Ka (M-1)
galactose

Selectivity
Ka glucose/Ka
fructose

Fluorescence
intensity
changes for
glucose

25

2540 ± 90.1

968 ± 126.6

271 ± 37.5

3

10-fold
increase

26

1808 ± 130.6

198 ± 32.8

132 ± 60.5

9

2-fold
increase

27

630 ± 48.6

42 ± 7.2

46 ± 6.6

15

4-fold
increase

10a

1472

34

30

43

7-fold
increase
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Table 1.2. Binding Constant (Ka) for monoboronic acids 29-31 and 10b with different
saccharides
Ka (M-1)
fructose

Compound

Ka (M-1)
glucose

Selectivity
Ka fructose/Ka

29

1350 ± 68.4

101 ± 5.2

13

Fluorescence
intensity changes
for fructose
2.3-fold increase

30

714 ± 51.3

40 ± 4.0

18

2-fold increase

31

650 ± 29.2

26 ± 8.3

25

2.3-fold increase

10b

940

50

18

2- fold increase

glucose

Overall, the results indicate that the substituent effect on monoboronic acids can
only be partially translated into the same kind effect when used for the preparation of
bisboronic acid compounds. Other factors such as conformational changes may also need
to be considered in designing analogs aimed at optimizing the affinity and selectivity of
the interested sensors.
There is one additional point that is worth discussing, i.e., why the substituent
electron-withdrawing ability did not correlate with the apparent binding constants of the
monoboronic acids (10b, and 29-31) (Tables 1 and 2). As has been reported previously,
the apparent binding constant of a particularly boronic acid can be affected by several
factors including (1) the pKa values of the boronic acid and the diol, (2) the optimal pH
for a particular complexation reaction, (3) steric factors, (4) the concentration and nature
of the buffer, (5) whether trivalent interaction is involved, and (6) other idiosyncratic
factors that have not been identified.19 Among these factors, a shift of the optimal pH
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away from 7.4 to a lower pH is most likely the reason for the diminished intrinsic affinity
of 29 and 30 for diols at pH 7.4 compared with the un-substituted one (10b). Similar
examples have been reported before, especially with boronic acids that have a very low
pKa value.19
1.5.

Conclusions
Three new fluorescent anthracene-based bisboronic sensors (25-27) and three

monoboronic fluorescent sensors (29-31) were synthesized. Both cyano- (25) and nitrosubstituted (26) sensors had higher apparent binding constant for glucose (K 2540 M-1
and 1808 M-1 respectively) than the parent sensor (10a) (1472 M-1). Whereas fluorosubstituted bisfluoroboronic acid (27) had a lower apparent binding constant (K 630M-1)
but it has the most appropriate affinity and selectivity for glucose sensing under
physiological conditions. The selectivity between glucose and fructose did diminish for
all the new sensors (25-27) compared to 10a. The monoboronic acid series sensors (2931) also showed similar trend in the affinity for saccharides compared with their
bisboronic acid analogs. Again, monofluoroboronic acid sensor (31) had the lowest
binding constant but showed a greater selectivity (25 fold) than 29 for fructose over
glucose. Overall, the introduction of an electron-withdrawing group does not always
directly translate into enhanced affinity, and the affinity of the bisboronic sensors only
partially tracks that of the monoboronic building blocks. The effect of the electronwithdrawing group in the selectivity of the bisboronic acid sensors is hard to predict.
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1.6.

Palladium catalyzed synthesis of sterically hindered arylboronic esters

1.6.1. Contributions
The goal of this project was to study the new borylating agent (bis(neopentyl
glycolato)diboron) for the palladium catalyzed synthesis of hindered arylboronic acid. In
this methodology study 12 ortho substituted boronic esters were synthesized. Dr. Hao
Fang synthesized 7 boronic esters and I synthesized 5 boronic esters. Detailed synthesis
of boronic esters that I performed will be given with full characterization.
1.6.2. Introduction
Generally, two methods are used to synthesize arylboronic acid or ester compounds.
One is the transmetalation between an arylmetal and a boron halide or alkoxide;53 the
other is the recently developed PdCl2(dppf)-catalyzed borylation of aryl halides,54
triflates55, 56 and diazonium57, 58with a tetra(alkoxy)diboron

54, 55, 57

or dialkoxyborane

reagent.56, 59 The palladium-catalyzed method can be used for the borylation of substrates
that contain functional groups such as cyano, nitro, amino, hydroxyl, ester and carbonyl
groups, which may not be compatible with organometallic agents such as n-butyllithium.
Currently, bis(pinacolato)diboron (32) is the most widely used agent in palladium
mediated borylation reactions due to its commercial availability and good stability in the
presence of water and during chromatography.60
In the synthesis of boronic esters, many problems were encountered when
bis(pinacolato)diboron was used as the borylation agent. For example, complicated
reaction mixtures were obtained in the preparation of ortho-methoxy-substituted
phenylboronic acid, which led to low yields (about 20%).61 Similar results have also been
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reported in the literature,54although a few exceptions were reported when aryltriflates
were used instead of arylhalides.55 Baudoin and coworkers utilized pinacolborane
(Me4C2O2)BH to synthesize phenylpinacol boronic esters from ortho-substitued aryl
bromides and found the best catalyst being Pd(OAc)2 in the presence of 2-(dicyclohexyl
phosphino)biphenyl which is a sterically hindered phosphine ligand,59 although the yields
were still poor when functional groups such as nitro (20%), acetyl (0%), and Boc
protected amino group (40%) were present. Later Miyaura’s group reported that
Pd(dba)2/PCy3 could be used to carry out borylation of some ortho-substituted
chloroarenes (nitro and methoxy) by using bis(pinacolato)diboron (70% yield based on
GC after 48 hours of reaction).62 Most recently, a new N-heterocyclic carbene-palladium
catalyst was used to borylate ortho-methoxy substituted aryldiazonium with good yields
using bis(pinacolato)diboron.58

O
O
B B
O
O
32

O
B B
O
O

O

33

Figure 1.7. Bisborylating agents (a) bis(pinacolato)diboron (b)
bis(neopentylglycolato)diboron
So far, research in this area has been focused on examining the effect of different
leaving groups or designing or experimenting new palladium catalysts. We envisioned
that some of the problems might be overcome by manipulating the steric bulkiness of the
borylation agent. In our very first example, we examined the borylation of 2-methoxy-5-
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nitrophenylbromide using the new commercially available bis(neopentyl
glycolato)diboron 33 in the presence of PdCl2(dppf) and observed much improved yield
compared with the reaction using bis(pinacolato)diboron as the borylation agent (72% vs.
20%) under similar conditions (Scheme 1.7.). Such results suggested that the steric
bulkiness of the tetra(alkoxy)diboron agent may play an important role in the borylation
of other ortho-substitutent arylhalide (bromide in this case) and a less hindered
bis(neopentyl glycolato)diboron might be used to overcome the side reaction problems
associated with the use of sterically bulky bis(pinacolato)diboron.

R
Br
34

O
O
B B
O
O
33
PdCl2(dppf), KOAc
DMSO, 80 oC

R
B
O

O

35

Scheme 1.7. General synthesis route to neopentyl protected boronic ester

1.6.3. Synthesis of ortho-substituted aryl boronic esters
In order to understand the scope of the effect of the steric bulkiness of the borylation
agent, we were interested in examining the borylation of a series ortho-substituted
arylhalides. As a first step, we optimized the reaction conditions with respect to the
solvent and base used. As expected and has been observed with reactions using the
bis(pinacolato)diboron borylation agent, DMSO was the best solvent and KOAc was the
best base. Toluene and dioxane exhibited low reaction rate with more debromo product.
The reaction did not work when using triethylamine as base.

23

The borylation of 12 additional arylhalides were studied using this method (entry 213, Table 1.3). In most cases, the reaction was completed within 4 hours. Good (65%) to
excellent (90%) yields were obtained in most cases except with 8-quinoline analog (entry
9, 35%), 2-bromophenol (entry 11, 5%), and 2-bromobenzaldehyde (entry 13, 7%).
Unexpectedly, borylation of Boc protected 2-bromoaniline (entry 3) gave the deprotected
aniline neopentyl glycolato boronate. The mechanism through which the Boc group was
cleaved is unclear. Comparing with literature and our own research results, the yields
were much better than the reactions using bis(pinacolato)diboron or pinacolborane as the
borylating

agent.

For

example,

ortho-bromonitrobenzene

(entry

4)

and

2-

bromomethylphenylketone (entry 8) gave yields in the range of 0-20% when
pinacolborane was used as the borylating agent.59 Even when the corresponding
iodoarene was used for the nitrobenzene analog, the yield was still low (44%).59 In
contrast, the corresponding reactions using bis(neopentyl glycolato)diboron as the
borylation agent gave over 68% isolated yields for both nitro (entry 4) and acetyl
substituent (entry 8).
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Table 1.3. Representative Reactions
Entry

Br

1

Time (h)

3 (%)a

35a

2

72

35b

2

69

35b

4

65

35d

3

68

35e

4

(90)

35f

4

80

35g

6

73

35h

3

70

35i

12

35

35j

12

85

35k

12

5

35k

8

70

35
m

12

7

Product 3
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OCH3
O
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O
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O2N

O2N

NH2

NH2

2

Br
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3

NH2
O
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O

34c
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NO2

4

O
B
O

34b

NO2
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O

34d

B
O

F

F

5

Br

O

34e

B
O

CO2CH3

6

34f

Br
CN

7

Br

34g

O

CO2CH3
O
B
O
CN
O
B
O

O

8

Br

O

34h

B
O
NHBoc

NHBoc

9

34i
N
B(OH) 2

N
Br

10

N Boc

N

34j

Br

OH

11

N Boc

N
B(OH)2

OH

Br

34k

O
B
O

OH

12

OH

I

34l

O
B
O

CHO

13
a

Br

34
m

CHO
O
B
O

isolated yield after flash chromatography. Yields in parentheses are GC yields.
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On a somewhat different note, where steric hindrance may not necessarily be a
factor, the borylation of quinoline bromide also benefited from using bis(neopentyl
glycolato)diboron instead of bis(pinacolato)diboron as the borylation agent.

For

example, in the borylation of 8-bromoquinoline derivatives (Entries 9 and 10), Suzuki
coupling product was the major product when bis(pinacolato)diboron was used as a
borylation agent in the presence of KOAc.63 However, when bis(neopentyl
glycolato)diboron was used, Suzuki coupling product was not formed in the reaction
mixture and the corresponding 8-quinoline boronic acid was easily obtained.
It does need to be noted that entry 13 (with a formyl substituent) gave less than 10%
yield of the desired product with the formation of 20% Suzuki coupling product and the
recovery of 50% of the starting material. In addition, entry 11 (hydroxyl group) gave only
5% yield of the desired product with over 85% of the starting material recovered, while
the corresponding iodide (entry 12) gave a good yield (70%). It is not clear why the
hydroxyl group (entry 11) and the formyl group (entry 13) presented special problems.
In an effort to improve the yields for entries 11 and 13, we also examined whether
different catalysts would be able to facilitate these two reactions. Previous work in the
Baudoin59 and Miyaura groups62 indicates that a more reactive palladium catalyst may be
able to improve yield of entry 11. Several air stable and more active palladium catalysts,
such as [(t-Bu)2P(OH)]2PdCl2 (POPd), {[(t-Bu)2P(OH)][(t-Bu)2P(O-)]PdCl}2 (POPd1),
and [(t-Bu)2P(OH)PdCl2]2 (POPd2), have been employed for cross-coupling reactions of
aryl chloride,64-66 and also for borylation of 5-bromofluorescein diacetate.67 Therefore,
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the new active palladium catalyst, POPd, was examined in the borylation of 2bromophenol and 2-bromobenzaldehyde.
Different palladium catalysts and solvents were examined in order to search for a
condition that would give a reasonable borylation yield from 2-bromophenol (Table 1.4).
The results showed that the POPd facilitates the borylation reaction and works better than
Pd(PPh3)4 and PdCl2(dppf) in DMSO (entries 1-3). When the temperature was raised to
120 ºC, 40% of the desired borylation product was obtained, with the remaining portion
being the un-reacted starting material (entry 4). When the solvent was changed to
toluene and dioxane, the debromo product (36) was the main product (entries 6 and 7).
Therefore, it seems that for the borylation of 2-bromophenol using POPd in DMSO at
120 ºC gives the best yield. When applying the same conditions to the borylation of 2bromobenzaldehyde, the starting material completely disappeared with the formation of
35% (isolated yield) of the desired borylation product and the remaining being the Suzuki
coupling product
Table 1.4. Different Palladium Catalysts in the Borylation of 2-bromophenol and 2bromobenzaldehyde
O
O
B B
O
O
33

X
Br

X

Catalyst, KOAc

34 k X = -OH
m X = -CHO

B
O

O

35 k X = -OH
m X = -CHO

Entry

Catalyst

Solvent

1

Pd(PPh3)4
(6%mol)

DMSO

Heating method
(temp. oC, time)
100, 12h

X
H
36 k X = -OH
m X = -CHO

Product ratio
34k:35k:36ka
100:0:0
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2
3
4
5
6
7

PdCl2(dppf)
(6% mol)
POPd (3% mol)
POPd (3% mol)
POPd (3% mol)
POPd (3% mol)
POPd (3% mol)

DMSO

100, 12h

93:7:0

DMSO
DMSO
DMF
Toluene
Dioxane

80, 12h
120, 12h
80, 12h
80, 12h
80, 12h

78:22:0
60:40:0
74:27:0
0:27:73b
0:10:80b

a

Determined by GC-MS
Determined by 1H-NMR

b

1.7.

Conclusions
Palladium catalyzed borylation of arylbromide is a very convenient way for the

preparation of arylboronic acids.

However commonly used borylation reagent,

bis(pinacolato)diboron, gives low yields and side reactions for ortho-substituted
bromoarenes, possibly due to the steric hinderance presented by the ortho substitutent.
This problem can be overcome by using a less hindered borylation agent, bis(neopentyl
glycolato)diboron, in most of cases. With the two cases (ortho substituent being a
hydroxyl or a formyl group) that give low yields of the borylation product, the problem
can be addressed by using a new and more active palladium catalyst, such as POPd.
1.8.

Experimental

1.8.1. General Procedures
All air- and water sensitive reactions were performed under dry Nitrogen in oven
dried glassware. Commercially available reagents were used without additional
purification unless otherwise indicated. Dichloromethane was distilled from CaH2. THF
was distilled from sodium and benzophenone.
Analytical thin layer chromatography (TLC) was performed with Scientific
Adsorbents plastic-baked TLC silica gel 60 F hard layer plates. TLC plates were
28

visualized with UV light (254 nm) or with 5% (w/v) solutions of phosphomolybidic acid
in ethanol. Flash chromatography was performed with Scientific Adsorbents silica gel
(flash 32-63 nm).
Mass spectrometry (MS) analyses were performed by the Mass Spectrometry
Laboratories of Georgia State University. 1H and 13C NMR spectra were recorded at 75
MHz and 100 MHz. Chemical Shifts (δ) are given in ppm relative to TMS for 1H spectra
and relative to residual solvent for 13C spectra.
1.8.2. Fluorescence Binding Study Procedure
Fluorescence measurents were used to determine the bidning between boronic
acid (BA) and saccharide. Fluorescence polarization is a measure of rotatational
relaxation time, so upon binding of a small molecule to a large molecule the fluorescene
polarization of small molecule changes which in turn reflects the relaxation time of the
large molecule. This effect indicates the binding event. The relationship between
fluorescence intensity change and the equilibrium constant can be expressed using
equation 1. At sufficiently low concentration where a plot of ∆If vs. concentration sugar
complex is linear:
∆If = 1+ K1 [Sugar]

Equation 1

A plot of 1/∆ If vs 1/[Sugar] gives K1= intercept / slope
A Shimadzu RF-5301PC fluorometer was used for all the fluorescent studies.
For a typical fluorescent measurement, a 2 mL of sensor stock solution in methanol (2.0
× 10-6 M) was mixed with 2 mL of saccharide solution in 0.1 M of phosphate buffer (pH
7.4) at various concentrations.

The apparent pH was checked with pH meter and
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corrected if necessary. The mixture was allowed to mix for 20 min and fluorescence
intensity was recorded.

Triplicate measurements were taken for each sugar. The

correlation coefficients for all determinations in fitting the 1:1 model were over 0.98.
1.8.3. General Procedure for the Synthesis of Arylboronates
A mixture of palladium catalyst (0.03eq), potassium acetate (3eq), bis(neopentyl
glycolato)diboron (1.2eq) and arylbromide was added to a flask in a glove box under
anhydrous condition. After addition of anhydrous DMSO (8 mL/mmol), the mixture was
stirred at 80 0C several hours checked by TLC. The reaction solution was cooled to room
temperature and poured into ice-water. The mixture was extracted with ethyl acetate and
the combined organic layers was washed with saturated brine, dried over MgSO4, and
concentrated in vacuo. The residue was purified by flash column chromatography to give
the corresponding arylboronates.
1, 10-Diexpoxide-anthracene (12). The preparation followed the literature procedure.52
A stirred suspension of anthraquione (4.0 g, 1mmol) and sodium hydride (2.2 g, 2.5
mmol) in ahydrous DMSO was added dropwise to a solution of trimethylsulfonium
iodide (11.0 g, 2.5 mmol) in anhydrous DMSO at room temperature over a period of 30
min and stirred for another 3h. The mixture was filtered and the filtrate was poured into
350 ml ice water. The mixture was allowed to stand for 2h, and then the precipitate was
washed with water and dried under vacuum at 45 o C overnight giving the diexpoxide in
92 % yield with no further purification. 1HNMR (300 MHz, CDCl3) δ: 3.25 (4H, s), 7.38
(8H, d, J = 1.2 Hz) ppm, was in agreement with the literature data.52
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10-Hydroxymethyl-anthracene-9-carbaldehyde (13). Compound 12 (3.3 g, 1mmol)
was added to stirred solution of lithium bromide (19.3 g, 5 mmol) in dry CH3CN, and the
mixture was stirred at 60 o C in the dark for 16h and then was cooled to -40 o C in a dry
ice-acetonitrile bath. The resulting product were collected by filtration, washed with
water, and dried overnight under vacuum to give 13 in 94% yield.

1

HNMR (300 MHz,

CDCl3) δ: 5.67 (2H, s), 7.64 (4H, m), 8.54 (2H, d, J = 8.4 Hz), 8.87-8.89 (2H, q, J = 1.5,
6 Hz), 11.47 (1H, s) ppm, was in agreement with the literature data.52
10-Methylaminomethyl-anthracen-9-yl)-methnaol (14). An aqeous solution of
methylamine (40% wt, 25 mL) was added to the solution of compound 13 (0.48 g,
1mmol) in MeOH (10 mL) and THF (5 mL) and stirred at room temperature for 16h. To
the stirred mixture was added sodium borohydride (0.39 g, 5 mmol). The solution was
stirred for another 30 min. After solvent evaporation, the resulting solid was dissolved in
EtOAC (10 mL). The solution was washed with water (2 x 20 mL) and brine (20 mL),
dried over MgSO4 and concentrated. The resulting crude product was purified with silica
gel column with eluent of MeOH/CH2Cl2 to give compound 14 in 95 % yield.

1

HNMR

(300 MHz, CDCl3) δ: 2.68 (3H, s), 4.69 (2H, s), 5.67 (2H, s), 7.55 (4H, m), 8.40-8.46
(4H, m) ppm, was in agreement with the literature data.36
(10-Hydroxymethyl-anthracene-9-ylmethyl)-methyl-carbamic acid tert-butyl ester
(15). Compound 9 (0.49 g, 1mol), di-tert-butyl dicarbonate (2.5 g, 2.5 mmol) and
triethylamine (5 mL) were mixed in MeOH (30 mL), and the mixture was stirred at room
temperature for 30 min. After removal of the solvent, the resulting residue was dissolved
in DCM (10 mL). The solution was washed with water (3 x 10 mL), and saturated brine
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(15 mL), dried over MgSO4 and concentrated. The resulting compound was dried under
vacuum to give 15 in 94 % yield. 1HNMR (300 MHz, CDCl3) δ: 1.57 (13H, s), 2.48 (3H,
s) 5.50 (2H, s), 5.70 (2H, s), 7.59-7.52 (4H, m), 8.50-8.42 (4H, m) ppm, was in
agreement with the literature data.36
(10-Formyl-anthracene-9-ylmethyl)-carbamic acid tert-butyl ester (16). Compound
15 (0.64 g, 1 mmol) was dissolved in the mixture of dry DMSO (10 mL) and
triethylamine (15 mL). To the solution was added the solution of pyridine sulfur trioxide
(1.76g, 6 mmol) dissolved in dry DMSO (5 mL) over period of 30 min, and then was
poured into ice water (200 mL). The mixture was extracted with EtOAc (3 x 20 mL),
dried over MgSO4 and concentrated. The resulting solid gave 16 in 99 % yield. 1HNMR
(300 MHz, CDCl3) δ: 1.56 (9H, s), 2.50 (3H, s), 5.56 (2H, s), 7.64-7.25 (4H, m), 8.53
(2H, d, J = 8.4 Hz), 8.91 (2H, d, J = 9.6 Hz), 11.51 (1H, s) ppm, was in agreement with
the literature data.36
Methyl-(10-methylaminomethyl-anthracen-9-ylmethyl)-carbamic

acid

tert-butyl

ester (17). Compound 16 (0.61 g, 1 mmol) was dissolved in THF (10 mL) and MeOH
(20 mL). To this solution was added an aqueous solution of methylamine (40%, wt, 20
mL), and the resulting reaction mixture was then stirred at room temperature under N2 for
12h. Sodium borohydride (0.33 g, 5 mmol) was added, and the reaction mixture was
stirred for 30 min. The mixture was concentrated and dissolved in CH2Cl2. The solution
was washed with water (2 x 10 mL) and brine (20 mL), dried over MgSO4 and
concentrated. The resulting crude product was purified on silica column, eluting with
CH2Cl2/MeOH (20/1), giving compound 17 in 74% yield. 1HNMR (300 MHz, CDCl3) δ:
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1.56 (9H, s), 2.48 (3H, s), 2.70 (3H, s), 4.72 (2H, s), 5.51 (2H, s), 7.25-7.58 (4H, m),
8.38-8.42 (4H, dd, J = 2.4, 1.2 Hz) ppm, was in agreement with the literature data.36
Boc-protected diamides (18). Compound 17 (0.73 g, 1 mmol), was added to a solution
of

(2-Carboxymethyl-phenyl)-acetic

acid

(0.19

g,

0.5

mmol),

1-(2-diemthyl-

aminopropyl)-3-ethylcarbodiimide hydrochloride (EDC. HCl, 0.77 g, 2 mmol), (HOBT,
0.27g, 1 mmol), (DMAP, 49 mg, 0.2 mmol), TEA (200 µL) in dry CH2Cl2 (60 mL), and
the mixture was stirred at room temperature at room temperature under N2 for 12h. The
solution was washed with 10% citric acid (10 mL), and water (2 x 20 mL), and was dried
over MgSO4 and concentrated under vacuo. The residue was purified on silica gel
column, eluting with Hexane/EtOAc (1/1) to give 18 in 54% yield. 1HNMR (300 MHz,
CDCl3) δ: 1.59 (22H, s), 2.27 (6H, s), 2.36 (6H, s), 3.71 (4H, s), 5.46 (4H, s), 5.66 (4H,
s), 7.27 (4H, s), 7.49 (8H, t, J = 8.1 Hz), 8.42 (8H, t, J = 7.2 Hz) ppm, was in agreement
with the literature data.36
4-Fluoro-2-methyl-boronic acid (22).

Commercially available 1-bromo-4-fluoro-2-

methyl-benzene 21 (1.02 g, 1mmol) was dissolved in dry THF (15 ml) and treated with nBuLi (2M in pentane, 1.3 mmol) at -78 o C for 1 hour under N2. Trisopropyl borate (1.62
ml, 1.3 mmol) was added drop wise into the flask and reaction was mixed for overnight at
room temperature. The reaction was treated with 1N HCl (20 mL) for 1 hour and
extracted with ethyl acetate (3 x 10 mL), and was dried over MgSO4 and concentrated
under vacuo to give free boronic acid 17 in 75 % yield. 1HNMR (400 MHz, CDCl3) δ:
2.42 (3H, d, J = 36.8 Hz), 6.81- 6.92 (2H, m), 7.25-7.45 (1H, t(t), J = 7.6 Hz ) ppm, was
in agreement with the literature data.68
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2-(4-Fluoro-2-methyl-phenyl)-5-methyl-[1,3,2] dioxaborinane (23).

Compound 22

(0.64 g, 1 mmol) and neopentyl glycol (0.52 g, 1.2 mmol) were mixed in toluene and
refluxed for 18 hours in a Dean-Stark setup. Reaction was cooled to room temperature
and solvent was evaporated. Crude product was chromatographed on silica column using
hexane-ethyl acetate as eluent to give 23 in 83%. 1HNMR (300 MHz, CDCl3) δ: 1.03
(6H, s), 2.51 (3H, s), 3.76 (4H, s), 6.81(2H, m), 7.88 (1H, t, J = 6.9 Hz) ppm, was in
agreement with the literature data.68
2-(2-Bromomethyl-4-fluoro-phenyl)-5,5-dimethyl-[1,3,2]dioxaborinane (24).
Compound 23 (0.66g, 1mmol) was brominated in the presence of NBS (0.58g, 1.1mmol)
and catalytic amount of AIBN (10mg) and refluxed in benzene for 18 hours. Crude
product was chromatographed on silica column using hexane-ethyl acetate as eluent to
give 24 in 68%. 1HNMR (300 MHz, CDCl3) δ: 1.09 (6H, s), 3.84 (4H, s), 4.94 (2H, s),
7.02 (1H, t, J = 8.4 Hz), 7.10-7.15 (1H, dd, J = 2.4, 7.5 Hz), 7.88 (1H, t, J = 6.9 Hz)
ppm, was in agreement with the literature data.68
(25). BOC protected diamide compound 18 (127 mg, 14 mmol) was dissolved in 4ml dry
DCM and 2 ml of trifluoroacetic acid (TFA) was added to the flask. Reaction was stirred
for 30min at rt and solvent was removed and dried under vacuum. The deprotected
product, 19 (156mg, 0.50 mmol), potassium carbonate (175 mg, 1.27 mmol) and KI (6
mg) was dissolved in dried acetonitrile and mixed for 12 hours at rt. Solvent was
removed and resulted yellow precipitate was dissolved in (10 ml) DCM and 5ml 10%
NaHCO3 and stirred for 1 hour at rt. The organic phase was washed with water (2 ×
10ml), and dried over MgSO4 and solvent was removed in vacuo. The resulted residue
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was re-precipitated from DCM-ether to give 25 in 39%. 1HNMR (400 MHz, CD3OD) δ:
2.37 (6H, s), 2.63 (6H, s), 3.81 (4H, s), 4.22 (4H, s), 5.06 (4H, s), 5.74 (4H, s), 7.24 (4H,
s), 7.57 (9H, t, J = 8.8 Hz), 7.83 (4H, d, J = 7.2 Hz), 8.31 (4H, d, J = 7.6 Hz), 8.45 (4H,
d, J = 8 Hz) ppm. HRMS (ESI+): calcd for C62H58B2 N6O6: 1005.4663; found:
1005.4663. We were unable to remove cleaved neopentyl glycol, in order to confirm the
structure; the boronic acid was oxidized in the presence of acetic acid/water (1:1) and
H2O2 to obtain pure NMR. 1HNMR (400 MHz, CD3Cl3) δ: 2.41 (6H, s), 2.64 (6H, s), 3.81
(8H, s), 4.71 (4H, s), 5.72 (4H, s), 6.66 (2H, d, J = 8.4Hz), 7.23 (6H, s), 7.34-7.32 (3H,
dd, J = 2, 6.4 Hz), 7.54 (4H, t, J = 8.8 Hz), 7.63 (4H, t, J = 6.4 Hz) 8.44 (8H, q, J = 9.2,
12 Hz) ppm.

13

C NMR (100 MHz, CDCl3) δ: 22.58, 29.62, 33.37, 39.35, 41.85, 53.59,

59.52, 102.32, 116.85, 119.12, 122.84, 124.37, 124.76, 125.28, 125.64, 126.26, 126.42,
127.32, 128.55, 129.98, 130.52, 130.89, 131.17, 132.22, 132.42, 132.98, 133.12, 134.42,
161.58, 170.77 ppm. HRMS (ESI+): calcd for C62H56N6O4: 949.4442; found: 949.4479.
(26). The procedure was same as the preparation of 25 from 18. Yield (20%). 1HNMR
(400 MHz, CD3OD/CDCl3) δ: 2.37 (6H, s), 2.63 (6H, s), 3.80 (4H, s), 4.21 (10H, s), 5.73
(4H, s), 7.23 (4H, s), 7.56 (6H, t, J = 8.0 Hz), 7.86 (2H, d, J = 8.0 Hz), 8.07 (2H, s), 8.12
(2H, d, J = 8 Hz) 8.30 (4H, d, J = 8.4 Hz) 8.43 (4H, d, J = 8.4 Hz) ppm. HRMS (ESI+):
calcd for C60H58B2N6O10 : 1045.4479; found: 1045.4523. We were unable to remove
cleaved neopentyl glycol, in order to confirm the structure; the boronic acid was oxidized
in the presence of acetic acid/water (1:1) and H2O2 to obtain pure NMR. 1HNMR (400
MHz, CDCl3) δ: 2.44 (6H, s), 2.64 (6H, s), 3.80 (4H, s), 3.88 (4H, s), 4.73 (4H, s), 5.72
(4H, s), 6.64 (2H, d, J = 6 Hz), 7.26 (3H, s), 7.52 (4H, t, J = 8 Hz), 7.62 (4H, t, J = 6.8

35

Hz), 7.87 (2H, s), 7.95-7.93 (4H, dd, J = 2.4, 2.4 Hz), 8.41 (4H, t, J = 10 Hz) ppm. 13C
NMR (100 MHz, CDCl3) δ: 29.71, 33.48, 39.36, 41.66, 42.01, 53.50, 59.39, 116.17,
121.81, 124.36, 124.65, 125.22, 125.32, 126.36, 126.57, 127.44, 128.38, 130.04, 130.82,
131.10, 134.35, 140.05, 163.70, 170.74 ppm. HRMS (ESI+): calcd for C60H56N6O8 :
989.4238; found : 989.4252.
(27). The procedure was same as the preparation of 25 from 18, but the hydrolysis was
done in solution of acetone and water (1:4) in total volume of 150 ml and 1N HCl (10
ml). The reaction was stirred vigorously for 1hour at rt. The organic phase was washed
with water (2 × 10ml), and dried over MgSO4 and solvent was removed in vacuo. The
resulted residue was re-precipitated from DCM-ether to give 27 in 20%. 1HNMR (400
MHz, CD3OD/CDCl3) δ: 2.21 (6H, s), 2.42 (6H, s), 3.72 (4H, s), 4.11 (4H, s), 4.60 (4H,
s), 5.68 (4H, s), 7.09 (4H, q, J = 8.4, 9.6 Hz), 7.24 (4H, s), 7.48 (8H, s), 7.68 (2H, s), 8.27
(4H, s), 8.42 (4H, d, J = 6.4 Hz) ppm. HRMS (ESI+): calcd for C60H58B2F2N4O6- H2O:
973.4483; found: 973.4464. We were unable to remove cleaved neopentyl glycol, in
order to confirm the structure; the boronic acid was oxidized in the presence of acetic
acid/water (1:1) and H2O2 to obtain pure NMR. 1HNMR (400 MHz, CDCl3) δ: 2.34 (6H,
s), 2.61 (6H, s), 3.79 (8H, s), 4.67 (4H, s), 5.29 (4H, s), 6.62 (2H, q, J = 4.4, 4.8 Hz),
6.71 (2H, dd, J = 2.8 Hz), 6.77 (2H, d, J = 2.8 Hz), 7.23 (4H, s), 7.52 (4H, t, J = 8.4 Hz),
7.60 (4H, t, J = 8.4 Hz), 8.40-8.42 (8H, dd, J = 2.4, 2.8 Hz) ppm. 13C NMR (100 MHz,
CDCl3) δ: 29.71, 39.31, 41.66, 41.75, 53.59, 59.97, 114.78 (s (dC-F), J = 14 Hz), 115.01
(s (dC-F), J = 14 Hz), 116.49 (s (dC-F), J = 8 Hz), 122.69, 122.75, 124.63, 125.19, 126.29,
127.42, 129.14, 129.58, 130.08, 130.85, 131.07, 134.38, 153.11, 157.15 (s (dC-F), J =
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220 Hz), 170.72 ppm. HRMS (ESI+) calcd for C60H56F2N4O4 : 935.4348 ; found:
935.4351.
2-[(Anthracen-9-ylmethyl-methyl-amino)-methyl]-4-cyano-boronic

acid

(29).

Anthracen-9-ylmethyl-methyl-amine (120 mg, 0.54 mmol), 19 (183 mg, 0.60 mmol),
potassium carbonate (299 mg, 2.17 mmol) and KI (7.2 mg) was dissolved in dried
acetonitrile and mixed for 12 hours at rt. Solvent was removed and resulted yellow
precipitate was dissolved in (10 ml) DCM and 5ml 10% NaHCO3 and stirred for 1 hour at
rt. The organic phase was washed with water (2 × 10ml), and dried over MgSO4 and
solvent was removed in vaccum. The resulted residue was re-precipitated from DCMhexane to give 29 in 12%. 1HNMR (300 MHz, CDCl3) δ: 2.44 (3H, s), 4.23 (2H, s), 5.03
(2H, s), 7.55 (4H, m), 7.67 (1H, d, J = 7.8 Hz), 7.89 (1H, d, J = 7.5 Hz), 8.10-8.19 (4H,
dd, J = 8.4 Hz), 8.59 (1H, s) ppm. 13C NMR (100 MHz, CDCl3) δ: 43.15, 51.55, 112.24,
119.33, 124.92, 125.88, 128.08, 128.34, 129.08, 129.32, 130.09, 131.00, 131.39, 131.72,
133.79, 144.71 ppm.

HRMS (ESI+): calcd for C24H21BN2O2: 381.1774; found:

381.1774.
2-[(Anthracen-9-ylmethyl-methyl-amino)-methyl]-4-nitro-boronic acid (30). The
procedure was same as the preparation of 29. Yield (29%). 1HNMR (400 MHz, CDCl3)
δ: 2.25 (3H, s), 4.54 (2H, s), 5.15 (2H, s), 7.58 (4H, m), 7.97 (1H, d, J = 8 Hz), 8.14 (2H,
d, J = 8 Hz), 8.24-8.28 (4H, dd, J = 5.6, 6 Hz), 8.64 (1H, s) ppm. 13C NMR (100 MHz,
CDCl3 / CD3OD) δ: 42.29, 121.80, 124.24, 124.90, 126.08, 126.77, 128.57, 129.17,
131.38, 131.95, 135.88, 141.96, 143.07, 148.50 ppm. HRMS (ESI+): calcd for
C23H21BN2O4: 401.1672; found: 401.1670.
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2-[(Anthracen-9-ylmethyl-methyl-amino)-methyl]-4-fluoro-boronic acid (31).

The

procedure was same as the preparation of 29. Yield (53%). 1HNMR (300 MHz, CD3OD)
δ: 2.24 (3H, s), 3.98 (2H, s), 4.57 (2H, s), 7.06 (2H, m), 7.42-7.44 (4H, dd, J = 2.7, 3.3
Hz), 7.79 (1H, s), 7.94-8.00 (4H, dd, J = 3, 13.2 Hz), 8.39 (1H, s) ppm. 13C NMR (100
MHz, CDCl3 / CD3OD) δ: 38.39, 61.24, 112.81 (s (dC-F), J = 18 Hz), 115.52 (s (dC-F), J =
19 Hz), 122.32, 123.64, 125.38, 127.84, 128.28, 130.01, 130.16, 134.69, 141.96, 162.69
(s (dC-F), J = 243 Hz) ppm. HRMS (ESI+): calcd for C23H21BFNO2: 374.1727; found:
374.1717.
2-(2-fluorophenyl)-5,5-dimethyl-1,3,2-dioxaborinane (35e).
1

HNMR (400 MHz, CDCl3) δ: 1.03 (6H, s), 3.79 (4H, s), 6.99 (1H, t, J = 9.2, 9.6 Hz),

7.11 (1H, t, J = 7.6 Hz), 7.37 (1H, m), 7.72 (1H, t) ppm. 13C NMR (100 MHz, CDCl3) δ:
21.86, 31.81, 72.45, 115.45 (s (dC-F), J = 24Hz), 123.48 (s (dC-F), J = 3 Hz), 132.55 (s
(dC-F), J = 8 Hz), 136.21 (s (dC-F), J = 8 Hz), 165.90, 168.38 ppm. GCMS (EI): calcd for
C11H14BFO2: 208; found: 208.
Methyl 2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzoate (35f).
1

HNMR (300 MHz, CDCl3) δ: 1.13 (6H, s), 3.82 (4H, s), 3.94 (3H, s), 7.40 (1H, s), 7.53

(2H, d, J = 2.7 Hz), 7.79 (1H, s), 7.95 (1H, d, J = 7.8 Hz) ppm.

13

C NMR (100 MHz,

CDCl3) δ: 22.07, 31.82, 52.35, 72.54, 128.42, 128.64, 131.36, 131.96, 132.84, 169.09
ppm. GCMS (EI): calcd for C13H17BO4: 247; found: 247.
1-(2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)phenyl)ethanone (35h).

1

HNMR (400

MHz, CDCl3) δ: 1.13 (6H, s), 2.61 (3H, s), 3.81 (4H, s), 7.41 (2H, d, J = 1.2 Hz), 7.54
(2H, d, J = 4.8 Hz), 7.82 (1H, d, J = 7.6 Hz) ppm.

13

C NMR (100 MHz, CDCl3 ) δ:
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22.22, 38.39, 25.61, 31.84, 72.57, 128.40, 128.47, 131.37, 132.67, 140.12, 200.70 ppm.
GCMS (EI): calcd for C13H17BO3: 232; found: 232.
2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)benzaldehyde (35m).

1

HNMR (300 MHz,

CDCl3) δ: 1.10 (6H, s), 3.83 (4H, s), 7.56 (2H, m), 7.82 (1H, d, J = 6.9 Hz), 7.93 (1H, d,
J = 6.0 Hz), 10.47 (1H, s) ppm.

13

C NMR (100 MHz, CDCl3) δ: 22.26, 25.65, 31.89,

72.62, 128.45, 128.53, 131.41, 131.75, 140.39, 200.10 ppm. GCMS (EI): calcd for
C12H15BO3: 217; found: 217.
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Chapter 2. Regulating the fluorescence intensity of an anthracene
boronic acid System: A B-N bond or a hydrolysis mechanism?
Abstract: An anthracene-based fluorescent boronic acid system developed by the
Shinkai group as mentioned in Chapter 1 has been widely used for the preparation of
fluorescent sensors for carbohydrates. Such application is based on the significant
fluorescence intensity increase of this system upon binding with a carbohydrate. The
mechanism through which this fluorescence intensity change happens was originally
proposed to go through a B-N bond formation mechanism, which masks the nitrogen lone
pair electrons. However, our own fluorescence studies suggest a possible alternative
mechanism for the fluorescence changes upon the formation of a boronic acid (1a)
complex with diols. In this new proposed mechanism, complex formation induces
solvolysis, which results in the protonation of the amine nitrogen if the reactions are
carried out in a protic solvent such as water at physiological pH. This protonation
prevents the photoinduced electron transfer, resulting in reduced quenching of the
anthracene fluorescence and increased fluorescence. Such a solvolysis mechanism is
supported by evidence from various types of experiments and theoretical calculations.
This study for the first time establishes a detailed mechanism of the fluorescence
intensity changes of the anthracene boronic acid system (1a), which has been
misunderstood for the last decade.
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2.1.

Contributions
This chapter includes both theoretical data as well as experimental data for the

study. Dr. Weijuan Ni performed and collected theoretical data (section 2.10) and her
work has been included in this chapter as further evidence in support of our proposed
mechanism (hydrolysis mechanism).
2.2.

Introduction
Due to the unique strong interactions between boronic acids and diols through

reversible ester formation, there has been a great deal of interest in using boronic acids as
the recognition moiety for the development of fluorescent and color sensors,1-16
carbohydrate transporters,17-22 and chromatographic stationary materials.23-26 Various
fluorescent boronic acid compounds that show fluorescent intensity/wavelength changes
upon binding with diols to varying degrees have been developed.

1, 27-29

Critical to the

development of boronic acid-based fluorescent sensors is the availability of fluorescent
reporter compounds that change fluorescence intensities upon binding to a diol.10, 29-31 In
this regard, the Shinkai group, based on what was reported by Wulff earlier,32 has made
some of the most important contributions by taking advantage of the fluorescence/color
modulation effect of an amino group positioned in a 1,5 relationship to the boron atom of
a boronic acid moiety. One specific example is an anthracene-based fluorescent boronic
acid compound (1a, Scheme 2.1), which shows significant fluorescence intensity changes
upon diol binding.9, 27 It is well known that the nitrogen lone pair electrons can quench
anthracene fluorescence through photoelectron transfer (PET). Therefore, compound 1a
is only weakly fluorescent at physiological pH. Due to the proximity of the amine to the
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boron atom, a B-N bond can be formed leading to a five-membered ring (1b) at neutral
pH. Because diol binding often increases the Lewis acidity of the boron atom,28, 33, 34
carbohydrate binding has been proposed to result in the strengthening of the B-N bond in
2b, which makes the lone pair electrons less available for fluorescence quenching
through PET. The hypothesis was that B-N bond strengthening results in decreased
fluorescence quenching and increased fluorescence intensities in 2b. The same concept
has been the inspiration for the development of many other fluorescence or color boronic
acid reporter compounds.10,

31, 35

We have also applied the Shinkai system for the

preparation of sensors for mono- and oligosaccharides

17

and studied the effects of B-N

bond formation in such systems using density functional theory (DFT) methods. 36
Although this system (1a) has worked very well as a fluorescent reporter
compound, there are telltale signs that the mechanism through which such a system
works may not have to involve B-N bond formation as originally proposed. For example,
available crystal structures actually show a longer B-N bond for the ester than for the
acid. The bond lengths of the ester 37 and acid 7 determined by X-ray crystallography are
1.754 Å and 1.669 Å, respectively. Furthermore, James and co-workers have shown that
the fluorescence intensity of the sugar-1b complex is independent of the intrinsic pKa of
the boronic ester, which contradicts the B-N bond mechanism.38 Because of the enormous
role that molecule (1a) has played in the field of boronic acid-based sensor design, there
is a need to better understand the mechanism through which the fluorescence intensity
change occurs. An understanding of the mechanism will help the future design of
improved sensors.
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2.3.

Experimental

All the reagents were purchased from Aldrich or Fisher/Acros and used as received.
Anhydrous tetrahydrofuran (THF) was distilled from Na/benzophenone prior to use.
Acetonitrile (CH3CN) and dichloromethane (CH2Cl2) were distilled from CaH2.
All pH values were determined with an Accumet 1003 Handhold pH/mV/Ion Meter
(Fisher Scientific). A Shimadzu RF-5301 PC fluorometer was used for the fluorescence
studies.

The excitation wavelength was set at 370 nm.

A Shimudzu UV-1601

spectrophotometer was used for the UV absorption studies.
Synthesis of model compound 1a followed literature procedure.9, 27
2.4.

Experimental Design, Results and Discussions

To analyze the possible mechanisms through which fluorescence intensity changes
can occur, one can first write the different possible forms in which the boronic acid and
the boronic acid-diol complex can exist. Boronic acid can exist in the protonated form
when the pH is below its first pKa (1a). There are ample literature results proving that the
first pKa is the deprotonation of the amine with the concomitant formation of a B-N bond
(1b).7 The formation of (1b) results in a significant fluorescence intensity decrease
relative to (1a) despite the formation of the B-N bond.9, 27 Such results indicate that B-N
bond formation itself is not sufficient to “tie up” the lone pair electrons to prevent PET.
With the further increase of the pH, the hydroxide comes in to displace the amino group
to give 1c, which no longer has a B-N bond.
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With the addition of the diol, there are two possible scenarios, neither of which had
been experimentally proven or excluded at present before our studies, although we were
the first one proposing the solvolysis mechanism. In the first scenario, pKa1 of the ester
(2a) is the deprotonation of the amino group and the formation of the B-N bond (2b) as
originally proposed by Shinkai and co-workers. The second pKa is the replacement of the
B-N bond by a B-O bond leading to the formation of 2c. In the second scenario, shown
in the bottom of Scheme 2.1, the first pKa is the addition of the hydroxide to the boron
atom leading to the formation of 2d. The second pKa is still the same, leading to the
formation of 2c. The key difference between these two mechanisms is that under neutral
conditions, addition of a diol will lead to the formation of 2b in one mechanism (referred
to as the B-N bond mechanism) or 2d in the other. The latter will be referred to as the
hydrolysis mechanism since going from 1b to 2d corresponds to a hydrolysis of the B-N
bond as the boron forms a complex with a diol in 2d when the experiments are carried out
in an aqueous medium.
In order to analyze existing literature data and to design experiments that can help to
elucidate the mechanism, one has to analyze the possible experimental outcome under
different experimental conditions for these two possible mechanisms. In Table 2.1, we
have listed the expected experimental and/or computational outcomes that correspond to
each of the mechanisms.
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Table 2.1. Comparison of expected and observed phenomenon for the two different
mechanisms in Scheme 2.1.
Expected results for
the B-N bond
mechanism

Expected results for
the hydrolysis
mechanism

Results
observed

Observable for both
the acid (1) and the
ester (2)

Observable only for
the acid (1), not the
ester (2)

Observable only
for the acid (1)

Observable for both
the acid (1) and the
ester (2)

Observable only for
the ester (2), not the
acid (1)

Observable only
for the ester (2)

Fluorescence
intensity change in
anhydrous solvent

Intensity should
increase for ester

Intensity should
decrease for ester

Intensity
decrease for
ester

Magnitude of
fluorescence recovery
with different sugars

Different

Same

Same

Will not induce
fluorescence
intensity changes

Will induce
fluorescence
intensity changes

Fluorescence
intensity changes
observed

Very large

Small

Smalla

Phenomenon
Fluorescence
intensity change
associated with the
first pKa
Fluorescence
intensity change
associated with the
second pKa

The effect of
carbohydrates
engaged in trivalent
binding
B-N bond strength
difference between
the acid (1) and the
ester (2)
a
Computational results.

First, for the B-N bond formation mechanism (going from 2a to 2b to 2c) one would
expect to see a significant fluorescence intensity decrease associated with both the first
and second pKa’s since the deprotonation of the amino group and breaking the B-N bond
are both expected to affect the availability of the lone pair electrons. However, in the
hydrolysis mechanism (going from 2a to 2d to 2c) one would only expect to see a
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significant fluorescence intensity change associated with the second pKa since the first
pKa does not affect the protonation state of the amino group, and therefore does not affect
the availability of the nitrogen lone pair electrons in the PET process.
Second, since binding with different diols may result in the lowering of the boron pKa
to different degrees,28, 34 one would expect the B-N bond strength to be different in the
boronic acid complexes with different sugars. This difference in B-N strength should be
reflected in fluorescence intensity changes observed with addition of sugars if the B-N
bond formation mechanism is at work. However, if the hydrolysis mechanism is at work,
one would not expect to see a difference in the magnitude of the maximal fluorescence
recovery.
Third, binding studies carried out in anhydrous organic solvent would cause
fluorescence intensity to increase for the B-N bond mechanism due to formation of
complex 2b. If the hydrolysis mechanism is in play, the fluorescence intensity would
decrease because the lone pairs on the nitrogen are free to quench the fluorescence via
PET.
Fourth, there are some sugars that are known to bind to boronic acid in a trivalent
fashion.

5, 39, 40

If the B-N bond formation mechanism is the reason for the observed

fluorescence intensity change, one would not expect these trivalent sugars to cause a
fluorescence intensity increase because the trivalency prevents the B-N bond formation in
the sugar-boronic acid complex (2c).
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Fifth, if the strengthening of the B-N bond is the reason for the observed fluorescence
intensity changes with this system, one would expect the B-N bond in the boronic aciddiol complex (2b) to be much stronger than in the free boronic acid (1b).
With these expected differences in mind, we examined these factors one by one,
through experiments, computation and analysis of literature results. Fluorescent boronic
acid 1a was synthesized following the literature procedure.27 Density functional theory
(DFT) calculations were carried out using Dmol3 as described elsewhere.36
2.5.

pH profiles of the acid (1a) and various complexes

We first examine the pH profile of 1a. Shinkai’s original work has already shown
that there is a significant decrease in fluorescence intensity associated with the first pKa
of the boronic acid (1a), but not the second one.9, 27 We conducted the same experiments
under similar conditions, and obtained similar results (Figure 2.1.). This decrease in
fluorescence intensity associated with the first pKa makes sense since it has been
experimentally proven using a similar system that the first pKa is the deprotonation of the
amino group accompanied by B-N bond formation.7 Deprotonation unmasks the nitrogen
lone pair electrons and makes them available for PET. It should be noted that the
“affinity” of a proton for an amine group has been estimated to be in the range of 200
kcal/mol.41 This value may vary significantly depending on solvation and pKa, but even if
this “protonation affinity” is half of that number, it is still very strong, comparable to a
sigma covalent bond, and higher than the energy required to remove an electron from
amine nitrogen. On the other hand, the B-N strength is only a few kcal/mol,36 which
would not be able to “tie up” the nitrogen lone pair electrons nearly as effectively as
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protonation does in order to prevent PET. Such reasoning weighs in favor of a key role
for protonation of the amine rather than B-N bond formation as the trigger that alters the
fluorescence intensity.

Figure 2.1. pH titration profile of sensor 1a (2.25 × 10-6 M) at 25 °C in the presence ()
and absence () of D-glucose (0.05 M).
Along these lines, it becomes easy to understand why there is only a very small
fluorescence decrease associated with the second pKa in the case of the free acid (1b)
because breaking a ~3.6 kcal/mol B-N bond does not make much of a difference in the
PET process. As shown in a previous study, there is only a small effect on the driving
force for electron transfer or the reorganization energy. With the addition of a sugar such
as glucose, the pH profile of the complex is different.9, 27 The first pKa of the complex
(2a) is no longer associated with a large decrease in fluorescence intensity.

This

observation is not in agreement with the B-N bond mechanism since one would expect to
see a fluorescence intensity decrease when the amine nitrogen goes from the protonated
form to the B-N bond.

However, if the hydrolysis mechanism is at work, the
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observations can be very easily explained. In the boronic acid-diol complex, going from
2a to 2d does not involve the deprotonation of the amino group. Therefore, one would
not expect to see a large fluorescence intensity change associated with the first pKa of the
complex (2a) in the hydrolysis mechanism. With the second pKa, it is the deprotonation
of the amino group that is the reason for the significant decrease in fluorescence intensity.
Such a mechanism is also in agreement with the different results observed between the
acid (1a) and complex (2a). The B-N interaction itself is not sufficiently strong to tie up
the lone pair electrons to prevent PET, which is why the fluorescence intensity changes
were observed for the first pKa of the acid (1a), but not the ester (2a). These observations
also agree with DFT calculations that indicate that fluorescence quenching will occur in
the neutral B-N forms due to the reduction of the reorganization energy upon B-N bond
formation (or strengthening).36 The hydrolysis hypothesis also explains why fluorescence
intensity changes were observed for the second pKa of the ester (2d) and the first pKa of
the acid (1a) because again it is the deprotonation step that gives rise to fluorescence
intensity changes.
2.6.

Effect of anhydrous solvent on binding between sugar and 1a
To further study the protonation state of the amine, fluorescence study was

conducted in the anhydrous acetonitrile. Since the amino group cannot be protonated in
the absence of a protic solvent (the degree of protonation will be diminished, but not
completely absence, if there is trace amount of water), experiments in an anhydrous
solvent would allow us to probe the B-N bond effect on the fluorescent intensity of the
system upon sugar binding. If the hydrolysis mechanism is the reason for fluorescent
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intensity changes upon sugar addition in an aqueous environment, the addition of sugar in
an anhydrous solvent would be expected to cause the intensity to decrease since the lone
pair of electrons on the nitrogen become free upon sugar addition. Indeed, decrease in
fluorescence intensity was observed with addition of sugar in the anhydrous condition
(Figure 2.2). These results are consistent with the hydrolysis mechanism proposed in
Scheme 2.1.

Figure 2.2. Fluorescence intensity changes upon the addition of cyclopentanediol to
sensor 1a (2.0 × 10-5 M) in anhydrous acetonitrile. Cyclopentanediol conc. (mM): 0,
0.007, 0.012, 0.03, 0.045, 0.061, 0.086, 0.113, and 0.225.

2.7.

Effect of different sugars on the fluorescence intensity changes of 1a

It has been known for a long time that ester formation (2b) lowers the pKa of the
boron species to different degrees depending on the sugar/diol used.28,

34

We have

recently determined the apparent pKa values of the phenylboronic acid-diol complex with
various sugars/diols, and found that the apparent pKa drops 2-4 pKa units upon
complexation.28 For example, the apparent pKa of phenylboronic acid is about 8.8. The
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pKa values (or more precisely the apparent pKa’s under the experimental conditions) of its
fructose and glucose esters are 4.5 and 6.8 respectively. If the B-N bond mechanism is at
work, one would expect that the fluorescence intensity of the boronic acid-diol complex
to be dependent on the apparent pKa of the boron. One would also expect to see as much
change in fluorescence intensity when adding glucose to the free boronic acid and when
replacing the glucose with fructose because their apparent pKa separations (∆pKa) are
about the same. In other words, the fluorescence intensity of the glucose complex should
be much lower than that of the fructose complex because of the difference in their
apparent pKa. The same is true with the complex with other sugars. Aimed at studying
the effect of various sugars on the fluorescence intensity of 1a, we examined the binding
between 1a and fructose, glucose, sorbitol, and galactose, and found that these sugars
gave about the same maximal fluorescence intensities at saturating concentrations (Figure
2.3). Such results are consistent with those obtained in an earlier study by James and coworkers 38 and cannot be explained by the B-N bond mechanism, but are consistent with
the hydrolysis mechanism since the amine is in the same (protonated) state (2d) no matter
which sugar/diol is added.
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Figure 2.3. The effect of sorbitol (S), fructose (), galactose ( ), and glucose () on the
fluorescence intensity of 1 (2.25 × 10-6 M).

2.8.

B-N bond strength
As has been alluded to in the pH profile studies, in order for the B-N to play a role in

regulating the PET process two things have to happen.
First, the B-N bond needs to be so strong that it can “tie up” the lone pair electrons.
This would mean that the B-N bond strength in the ester (2b) is on the same scale as the
energy required transferring one nitrogen lone pair electron. The effect of protonation on
the PET process serves as a good reference point. Using mass spectrometry, it has been
determined that the proton affinity of an aniline amine is on the order of 215 kcal/mol.41
However, the B-N bond strength has been estimated to be at about 3.6 kcal/mol using
Density Functional Theory,36 which is far smaller than what is required to tie up the
nitrogen lone pair electrons to prevent PET.
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Second, the B-N bond strength difference upon diol binding should be large
compared to the B-N strength of the free acid (1b) in order to act as an on-off switch.
Again, our theoretical calculation indicates that (1) the B-N bond in an ester (2b) is not
much different from in the free acid (1b) form and (2) the change in bond strength upon
ester formation is probably no more than 2 kcal/mol.36 The first point would directly
contradict a B-N bond mechanism. Even if there is an increase in B-N bond strength
upon ester formation, such a small change is not expected to function as an on-off switch
as described in a B-N bond mechanism. On the other hand, the computational results and
the “proton affinity” experiments41 are all consistent with the hydrolysis mechanism.
2.9.

Experiments with trivalent sugars

There are several carbohydrates, including fructose and sorbitol that are known to
bind boronic acids in a trivalent fashion.28, 34, 40 If the B-N bond mechanism is at work,
one would expect that those sugars that complex to boronic acid in a trivalent fashion
would not induce a fluorescence intensity change upon binding since B-N bond formation
would not be possible. This is also a point raised by Norrild in a crystal structural study.39
Therefore, we tested the effect of fructose and sorbitol on the fluorescence intensity of 1a.
They both induced strong fluorescence intensity increases in a methanol-buffer mixed
solvent (Figures 2.4 and 2.5). It should be noted that the effect of fructose has already
been tested by Shinkai and co-workers and found to induce as much fluorescence
intensity changes as the other sugars tested.9, 27 This by itself already contradicts the B-N
bond mechanism, although the realization of fructose binding in a trivalent fashion came
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after the proposed B-N bond mechanism. Such binding results cannot be explained by the
B-N bond mechanism, but are consistent with the hydrolysis mechanism.

Figure 2.4. Fluorescence intensity changes upon the addition of fructose to sensor 1 (2.81
× 10-6 M) in 1:1 MeOH / 0.1 M aqueous phosphate buffer at pH 7.4. Fructose
concentration. (mM): 0, 0.04, 0.09, 0.21, 0.35, 0.88, and 2.09.

Figure 2.5. Fluorescence intensity change with addition of sorbitol to sensor 1 (2.81 ×
10-6 M) in 50% MeOH / 0.1 M aqueous phosphate buffer at pH 7.4. Sorbitol
concentration. (mM): 0, 0.03, 0.10, 0.17, 0.39, 0.83.
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2.10.

Density functional theory (DFT) studies of model systems

We have recently conducted DFT calculations of the B-N bond strength in a variety
of adducts including models for those shown in Scheme 2.1 and found that the B-N bond
strength to be very weak (< 7.2 kcal/mol) for all boronic acid and boronate ester adducts
with geometry observed experimentally and the change in B-N bond strength upon
formation of a boronate-ester is < 1 kcal/mol.36 The effect of the change in boronnitrogen interaction on the electron transfer rate constant was examined in detail.
Estimates of the driving force (energy change for electron transfer) and reorganization
energy were obtained. The DFT studies suggest that ester formation will actually
decrease the fluorescence yield in aprotic solvents, but will increase the fluorescence
yield in protic solvents.
In all the points raised above and the results observed or reported in the literature, any
single one is probably not enough to refute the B-N bond mechanism, but putting them all
together, it forms a very strong case in support of the hydrolysis mechanism going
through 2d and against the B-N bond mechanism. The hydrolysis mechanism is
essentially a pKa switch mechanism that we have used in the design of spectroscopic and
fluorescent boronic acid compounds, which changes spectroscopic and/or fluorescent
properties based on the ionization state changes.29, 42 In such a situation, there are two (or
more) ionizable functional groups in the boronic acid compound. In this case, it is an
amino and a boronic acid group. In the absence of any diol, the pKa of the amino group is
lower than that of the boronic acid moiety. Therefore, the first pKa of the free sensor (1a)
is that of the amino group. However, upon addition of a diol, the intrinsic pKa of the
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boronic acid is decreased, which results in the pKa of the boronic acid moiety in the
complex (2b) being lower than that of the amino group. In another words, the pKa order
of these two functional groups is switched with the addition of a diol. With sensor 1a, this
switch results in the protonation of amine nitrogen, which “ties up” the nitrogen lone pair
electrons and prevents PET quenching of the anthracene fluorescence.
2.11. Structural evidence of hydrolysis mechanism from other research groups
Recently, based on our proposed hydrolysis mechanism the Anslyn group has further
probed the structural and physical properties of different boronic acids and their complex
with sugars in understanding the mechanism.43 They used X-ray crystallography,

11

B

NMR, and computational analysis as their tools to elucidate the mechanism. X-ray crystal
structures of several boronic acids and their boronate forms were obtained from the
aprotic and protic solvent. They postualed that the crystals obtained from the aprotic
solvent would have the B-N bond whereas boronic acid crystal obtained from the protic
solvents would be in the hydrated form. Boronic acid crystal obtained from the aprotic
solvent of compound 3 showed B-N bond whereas compound 4 and 5 showed no B-N
bond. It was concluded that the B-N bond formation is effected by many forces and
crystal lattice packing can play a significant role. Crystal structure of complex 4 with
catechol revealed B-N bond formation in anhydrous condition whereas crystal obtain in
methanol showed methoxy group of solvent coordinated with the boron. Hence, it was
concluded that B-N bond formation in ester depends on the solvent from which the
crystal was obtained.
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B NMR studies results coincide with the X-ray crystal structure results where in

aprotic solvent boron atom adopts tetrahedral form by coordinating with nitrogen atom to
form B-N bond in the free acid and ester form. On the other hand in protic solvent boron
atom is fully solvated for both free and complexed boronic acid.
2.12.

Conclusions

In organic chemistry in general, it is always hard to prove a mechanism. This is no
exception. However, results from the pH profile studies of the free boronic acid and its
sugar complex, the effect of different sugars on the fluorescence intensity changes, the
effect of trivalent sugar on the fluorescence intensity of the boronic acid, structural
studies43 and the calculated B-N bond strength are all consistent with the hydrolysis
mechanism being the reason for the observed fluorescent intensity changes in this system.
Therefore, one can say with a high degree of confidence that based on available data, the
hydrolysis mechanism proposed is much more probable than the B-N bond mechanism.
The understanding of this mechanism helps the future design of more effective boronic
acid fluorescent reporter compounds for sensor and other applications as has been
demonstrated in some of our own work. 29, 42
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Chapter 3. Design and synthesis of boronic acid based sensors for sialic
acid for anti-influenza therapy
Abstract: A new series of fluorescent boronic acid based sensors for sialic acid were
designed and synthesized as potential anti-influenza agents. Three sensors were designed
on “two point” interaction. Two interactions points were: boronic acid group and
different amine based groups (amino/guandino/benzlyamine). Compounds (13, 15, 19)
were synthesized via [2+3] Huisgen cyloaddition reaction and were fluorescent at
micromolar range. Compounds 13 and 19 did not show significant fluorescence change
upon binding with sialic acid whereas the guanidine based compound (15) showed
significant spectroscopic change upon addition of sialic acid with binding affinity (Ka) of
8 M-1.
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3.1.

Introduction

3.1.1. Sialic acid structure
Sialic acids (SA) are nine carbon α-keto acids with many biological functions.
Sialic acid exits in many forms, main core structure is 2-keto-3-deoxy-D-glycero-Dgalacto-nonulosonic acid (1).1 Common modifications that occur in nature of SA are: 5amino group is either acetylated or glycolylated while all non-glycosidic hydroxyl group
at position 4, 7, 8, and 9 have been substituted with acetates, sulfates, phosphates, and
methyl ethers. Usually mono O-acetylation (3) occurs but di- or tri- acetylation in one
SA has also been reported. Such modifications can interfere with cell’s mode of action.
For example O-acetylation prevents the monosaccharide to be a counter-receptor for
influenza virus A and B whereas it is more susceptible to the binding of influenza virus
C.2 The most common form of sialic acid and almost only form found in humans is the
N-acetylneuraminic acid (2).3 Sialic acids rarely occur free in nature and are usually
found on the terminal ends of the cell surface glycoconjugates in mamals. They are found
in various linkages with the complex carbohydrates but mainly to galactose as Nacetylgalactosamine.1 Sialic acid are also found in sialy Lewis a and x tetrasaccharides
which have been associated with development and progression of certain types of
cancer.4 Due to their location at the terminal end and the negative charge of the
carboxylate functional group, sialic acids plays important role in mediating cellular
recognition and adhesion processes. Bacteria on the other hand do not normally produce
sialic acids on their own but some pathogenic strains can and they exhibit sialic acid on
their cell surface to mimic mammalian cells and evade the host’s immune system. 1
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Figure 3.1. Common sialic acid forms: 2-keto-3-deoxy-D-glycero-D-galactononulosonic acid (1), N-acetylneuraminic acid (2), and N-acetyl-9-Oacetylneuraminic acid (3)

3.1.2. Role of sialic acid in biological funtions and diseases
Mammals, including human beings and other various microorganisms have the
ability to produce sialic acids in a series of reaction from a simple precrursor, glucose.5
Mammailian nervous system contains the highest amount of sialic acid in the form of
gangliosides (65%), glycoproteins (32%) and the rest is in free form. However, in
humans the gangliosides are not present evenly; they are mainly concentrated in the brain
compared to other organs such as liver, lung, and spleen. Thus sialic acid moieties of
gangliosides and glycoproteins play a role in structural and functional roles of celluar
events such as cell recoginition, cell-to-cell contact, receptor binding, and other biosignal
transduction. 6 High content of sailic acid has also been found in human milk. Aside
from this property of cellular recognition and adhesion processes, the extent of outer
surface celluar sialyation has been related to the tumorogenesis and metatasis of certain
cancers. The N-glycolyneuraminic acid form of sialic acid is found mainly in animal
species but it has also been found in certain human cancers.3 It has also been reported that
the levels of circulating sialic acid are higher in Type II diabetic patients than in
nondiabetic patients.7
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3.1.3. Sialic acid: a key recognition molecule for influenza viral infection
Cell surface SA receptors has been considered to be critical for the influenza
virus.8 There are three types of influenza viruses: influenza B and C are human viruses
and influenza A virus is found in wide range of avian and mammalian hosts. Entry of the
virus into the host occurs through the glycoproteins present on the viral surface. In
specific, glycoproteins haemagglutinin (type A and B) and haemagglutinin esterase (type
C) attaches to host cell-surface molecules containing sialic acid. The process is followed
by endocytosis and fusion of viral membrane with the endosomal membrane which leads
to the entry of the virus.8, 9 Studies have indicated that sialylcells are main celluar targets
for the virus attachment to the host, in specific the N-acetyl-9-O-acetylneuraminic acid
(3) has been the key determinant in this process. Recent outburst of H5N1 avian
influenza flu or better known “bird flu” studies have also indicated haemagglutinin as a
key receptor on the virus surface for cellular attachment. As in other influenza infection
studies, the hemaggluctinin H5N1 also attaches to sialic acid receptors, specifically to
sialic acid linked to galactose in α2,3 (4) or α2,6 (5) fashion (Figure 3.2). Different
linkages have been important determinant for prefential binding of virus as well the
spread of the virus among species. Human influenza prefers to bind to sialic acid attached
to galactose in α2,6 linkage (SA- α-2,6-Gal) whereas avian influenza binds in α2,3
linkage (SA- α-2,3-Gal), thus the ability of virus to spread from avain to human is
difficult due to linkage barrier.10
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Since sialic acid is a key component for the influenza infection, we were
interested in designing boronic acid based sensors for the sialic acid as potential sensors
or drug targets for influenza therapy.
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Figure 3.2. Chemical structures of SA-α-2,3-Gal (4) and SA-α-2,6-Gal (5)

3.2.

Design of boronic acid based sensors for sialic acid

Boronic acids are known for their strong interaction with cis diols containing
compounds and such interactions has been employed in the design of sensors for cell
surface carbohydrates (chapter 1).4, 11, 12 As mentioned in chapter 1 a selective sensor
consist of three components: a) proper functional groups that afford strong intermolecular
interaction, b) a ‘reporting’ event/moiety that allows the binding event to be recognized,
and c) the appropriate three-dimensional scaffold that allow for necessary
complementarity in terms of size, shape, and functional group orientation. Taking in
account of all the essential components for a selective sensor, potential sensors for sialic
acid were designed using computer molecular modeling. Sialic acid bears a pair of cis
diols at positions 8 and 9 which make it a perfect substrate for boronic acid based sensor
design. Aside from having a pair of cis diols SA also has a carboxylate anion and sensors
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based on “two-point” interaction taking in account both the cis diol and carboxylate ionic
interactions have been reported. Shinkai et al reported the first PET (see Chapters 1 and
2) based chemosensors for sialic acid based on two-point interaction.13 Their design
included 1,10-phenanothroline-Zn(II) complex linked to aminomethylphenyl boronic acid
(Figure 3.3). The metal complex served as carboxylate binding site and boronic acid
group for diol binding. The receptor showed binding affinity (Ka) of 200 M-1 in an
aqueous methanol solution at pH of 8.0. A similar system based on two-point interaction
was reported by Takeuchi group where they designed surface plasmon resonance sensor
for detection of sialic acid.14 In there design p-vinylbenzeneboronic acid group interacted
with the cis diols and N,N,N-trimethylaminoethyl methacrylate interacted with
carboxylate group of the sialic acid. In a combinatorial effort, Bradley Smith and
coworkers have also worked on developing sialic acid sensors with limited success.15
They designed there scaffold on a polymer chain with two recognition domains:
conserved and variable. An anthracene based boronic acid acted as fluorophore and
conserved recognition domain. It was attached to a poly(allylamine) (PAA) chain with 50
free amines sites. After the attachment of the boronic acid moiety, the PAA chain was
futher derivatized to give several cationic sites on the chain that acted as variable
recognition domain. Several libraries were designed and tested with sialic acid, fructose,
and glucose. Fluorescence enhancement of 2-3 fold was seen among the libraries tested
but with low selectivity among the sugars.
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Figure 3.3. Complex structure of 1,10-phenanothroline-Zn(II) with sialic acid
As of today only limted examples of boronic acid based sensors are known for the
sialic acid detection, which only have moderate affinity and selectivity. The above three
examples of sensors for sialic acid have certains limitation. In Shinkai’s case, the receptor
was only soluble in high concentration of methanol and high pH (8.0) was required to
measure the fluorescence intensity changes. Such factors prevent them from being
employed in normal physiological conditions where aqueous media rather than organic
solvent are desired. To further enhance the solubility, binding affinity, and selectivity at
physiological pH of sensors for the sialic acid, we designed several potential sialic acid
sensors. Our designed also included two-point interactions where boronic acid unit would
interact with the diols and an amino/guandino/amidino unit will interact with the
carboxylate via hydrogen bonding and/or ionic interactions at physiological pH. Two
units (boronic acid and amine) in the sensor were set apart in a distance equivalent to that
between the cis diols and carboxylate anion in SA as shown in Figure 3.4. Three triazole
ring based sensors were designed and synthesized with different pKa values for the amine
units substituted to promote protonation at physiological pH (Figure 3.4 a vs Figure 3.4
75

b). The boronic acid (blue) was overlap with its complex (pink) with sialic acid to study
the sturctural difference between their free and complex form. The overlay indicates that
the sensor substituted with guanidine moiety has similar conformation when compared
between its free and complex form whereas aniline substituted sensor has poor overlap.
Such poor overlap translates into improper orientation of functional groups which are
necessary for the higher binding affinity of sensor for its substrate. Table 3.1 lists the
distance measured for the sensors and their complex. Their binding constants with sialic
acid were also determined (Table 3.2).

A

B

Figure 3.4. a) Structure of sensor 13 (blue) with its complex (pink) with sialic acid; b)
15 (blue) overlap with its complex (pink) sialic acid

76

Table 3.1. Measurements of bond lengths between boronic acid (BA) and amine (NH)
Sensor (BA-NH)
distance
(Ao)

Complex (BA-NH)
distance (Ao)

-H bond Length

13

9.362

8.005

2.126, 2.602

15

8.750

8.351

2.169, 1.900

19

8.364

7.774

2.108, 1.878

Sensor

3.3.

(Ao)

Synthesis of triazole based sialic acid sensors
Synthesis of aniline, benzyl amine, and guanidine based sensors were

accomplished with [2+3] Huisgen cycloaddition or “click chemistry” of an arylboronic
acid bearing a terminal alkyne group and arylazide. The building blocks, alkyne16 and
azide17, were synthesized by literature procedures. Briefly, the ethynylarylboronic ester
(10) was synthesised with the Sonogashira coupling using the 3-bromoarylboronic acid.
For the ease of purification, 3-bromophenhylboronic acid was first protected with pinacol
to give its ester (8) in 66 % yield. The Sonogashira coupling under microwave irridation
at 120 oC for 25 min gave the Sonogashira coupling product (9) in 78%. The
trimethylsilyl group was removed in presence of K2CO3 in methanol to give terminal free
ethynylbrononic ester in 97% yield (Scheme 3.1). Arylazides were prepared with
Ullmann type coupling of arylhalides in the presence of CuI. Azidoaniline (12) was
prepared by refluxing 3-bromoaniline with sodium azide in the presence of CuI to give
the desired azide in 97% yield. The 3-bromobenzylamine was first protected with di-tert77

butyldicarbonate in methanol in the presence of triethyl amine (TEA) and then its azide
was prepared with similar procedure as in the aniline case to give the desired product in
58% yield (Scheme 3.1). The guanidinoazide (14) was synthesized by reacting aniline
azide with the guanylating agent which was prepared by reacting 1H-pyrazole-1carboxamidine with di-tert-butyl dicarbonate in presence of 3 equivalents of lithium
hydride.18 Final triazole based compounds were obtained via copper catalyzed Huisgen
cycloaddition19 of amidoazide and alkyne in the presence sodium ascorbate to give
boronic ester and free boronic acid of respective amine . In the case of benzylamine (19)
and guanidine (15), the Boc protecting group was removed with trifluoroacetic acid to
give free amino groups (Scheme 3.1).
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Scheme 3.1. a) Pinacol, toluene, 120 o C; b) (CH3)3SiCCH, Pd(PPh3)3Cl2, CuI, PPh3,
diethylamine, DMF, 120 o C, MW; c) K2CO3, MeOH; d) NaN3, CuI, sodium ascorbate,
N,N-diethylethane-1,2-diamine, EtOH/H2O (7:3), reflux, N2; e) 10, CuSO4.5H2O, sodium
ascorbate, t-butanol/H2O(1:1); f) 1-H-Pyrazole-1-(N,N’-bis(tertbutoxycarbonyl)carboxamidine, MeCN; g) TFA(50%), DCM; h) di-tert-butyl
dicarbonate, MeOH, TEA

3.4.

Binding studies
The fluorescence experiments were conducted to determine the appropriate

binding constants of 13, 15, and 19 with sialic acid. Guandino based sensor (15) was
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completely soluble in phosphate buffer (pH 7.4) with a sensor concentration of 2 × 10-4
M. The aniline based sensor required 16% methanol and benzylaine required 8%
methanol for there complete solubility. The binding constants were determined with sialic
acid. Upon sugar addition, guanidine substituted sialic acid sensor analogs (15) showed
increased in fluorescence intensity whereas aniline and benzylamine substituted did not
show much change in fluorescence intensity. Figure 3.6 shows two sets of fluorescent
spectral changes upon sugar addition using compound 13 and 15 as examples.
The guanidino-substituted compound 15 showed the highest change in
fluorescence intensity with a 3-fold increase upon SA addition. It also showed the
highest binding affinity with an apparent binding constant (Ka) of 8 M-1 (Table 3.2). As
predicted the aniline-substitued (13) showed very weak binding due to presence of only
one binding unit (boronic acid) since aniline with a low pka was not protanated at
physiological pH and probably did not interacted with carboxylate group of the SA. The
benzylamine- substituted compound 19 did not show significant change in fluorescence
intensity to determine the binding constant.
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Figure 3.6. a) Fluorescence spectra of 13 (1.0 × 10-4 M) with sialic acid (0 mM-60 mM)
at 25 oC in 16% MeOH/0.1 M aqueous phosphate buffer at pH 7.4: λex = 300 nm. b)
Fluorescence spectra of 15 (1.0 × 10-4 M) with sialic acid (0 mM-65 mM) at 25 oC in 0.1
M aqueous phosphate buffer at pH 7.4: λex = 375 nm. c) Fluorescence spectra of 19 (1.0 ×
10-4 M) with sialic acid (0 mM-60 mM) at 25 oC in 8% MeOH/0.1 M aqueous phosphate
buffer at pH 7.4: λex = 288 nm

Table 3.2. Binding Constant (Ka) for compounds 13, 15, and 19 with sialic acid
Compound

Ka (M-1)

Fluorescence
intensity change

13

4.0

1-fold increase

15

8.0

3-fold increase

19

a

b

a: binding constant (Ka) could not be determined
b: no change in fluorescence intensity
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3.5.

Conclusions
Three new fluorescent triazole-based boronic sensors (13, 15, and 19) were

synthesized. Guanidine based sensor (15) had higher apparent binding constant for sialic
acid (K 8 M-1) under physiological conditions. On the other hand aniline and
beznylamine based boronic acids did not show binding affinity towards sialic acid.
Premiliary results indicate that guanidine based sensor is a potential target which can be
futher optimized to give better induce fit model to futher enhance the binding affinity.
3.6.

Future Prespective
Among the design sensors, the guanidine based sensor showed a low affinity

toward sialic acid but it is a potential target for further optimization. The design
optimization include
3.7.

Experimental

3.7.1. General Procedures
All air- and water-sensitive reactions were performed under dry nitrogen which
was passed through dryrite in oven-dried glassware. Commercially available reagents
were used without additional purification unless otherwise indicated. Dichloromethane
was distilled from CaH2. THF was distilled from sodium and benzophenone.
Analytical thin layer chromatography (TLC) was performed with Scientific
Adsorbents plastic-backed TLC silica gel 60 F hard layer plates. TLC plates were
visualized with UV light (254 nm) or with 5% (w/v) solution of phosphomolybidic acid
in ethanol. Flash column chromatography was performed with Scientific Adsorbents
silica gel (flash 32-63 nm).
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Mass spectrometry (MS) analyses were performed by the Mass Spectrometry
Facilities of Georgia State University. 1H and 13C NMR spectra were recorded at 400
MHz and 100 MHz. Chemical shifts (δ) are given in ppm relative to TMS for 1H spectra
and residual solvents for 13C spectra.
3.7.2. Procedures for Fluorescence Binding Studies
A Shimadzu RF-5301PC fluorometer was used for all the fluorescent studies. For
a typical fluorescent measurement, a 140 µL of sensor (2.0 × 10-4 M) stock solution in
methanol/ 0.1 M phosphate buffer was mixed with 140 µL of saccharide solution in 0.1
M of phosphate buffer (pH 7.4) at various concentrations. The apparent pH was checked
with pH meter and corrected if necessary. The mixture was allowed to mix for 10 min
and fluorescence intensity was recorded. Triplicate measurements were taken for each
sugar. The correlation coefficients for all determinations in fitting the 1:1 model were
over 0.98. The binding constants were determined by procedure as described in section
1.7.
2-(3-Bromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (8). A mixture of 3bromophenyl boronic acid 7 (14.9 mmol) and pinacol (17.9 mmol) was stirred in
refluxing toluene equipped with a Dean-Stark trap for about 24 h until evolution of water
ceased, then the solvent was removed on a rota-evaporator. The crude product was
purified by flash chromatography to give 8 in 66%. 1H NMR (400 MHz, CDCl3): 1.38
(12H, s), 7.28 (1H, t, J = 7.2 Hz ), 7.61 (1H, d, J = 7.6 Hz), 7.74 (1H, d, J = 7.2 Hz), 7.95
(1H, s) ppm.

13

C NMR (100 MHz, CDCl3): 24.86, 84.16, 122.46, 129.50, 133.09,

134.19, 137.48 ppm. MS-EI: calcd for C11H13BBrO2: 282; found: 282.
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Trimethyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethynyl)silane (9).
A mixture of aryl bromide (8) (0.9 mmol), Pd(PPh3)Cl2 (0.05 mmol), CuI (0.05 mmol),
triphenylphosphine (0.18 mmol), trimethylsilylacetylene (1 mmol), and diethylamine
(13.6 mmol) in dimethylformamide (DMF, 0.5 mL) was irradiated with microwave with
temperature maintained at 120 ºC for 20 ~ 25min in a heavy-walled glass vial sealed with
Teflon septum.

Then the reaction mixture was filtered and washed with

dichloromethane. The filtrate was concentrated under reduced pressure and the residue
was purified by flash chromatography to give 9 in 78%. 1H NMR (400 MHz, CDCl3):
0.23 (9H, J = 3.2 Hz) 1.34 (12H, s), 7.30 (1H, t, J = 7.6 Hz), 7.52-7.55 (1H, tt, J = 1.2,1.2
Hz), 7.72-7.74 (1H, dd, J = 1.2, 1.2 Hz), 7.93 (1H, s) ppm. 13C NMR (100 MHz, CDCl3):
0.01, 24.87, 83.99, 94.06, 105.07, 122.68, 127.58, 133.09, 134.58, 138.47 ppm. MS-EI:
calcd for C17H25BO2 Si: 300; found: 300.
2-(3-Ethynylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (10) A mixture of
trimethylsilylethynylaryl boronate 9 (0.5 mmol) and potassium carbonate (2 mmol) in
methanol (10 mL) was stirred at room temperature for 0.5 h ~ 2 h. Then the reaction
mixture was filtered, and the filtrate was concentrated under reduced pressure to give a
residue, which was purified by flash chromatography to give 10 in 77%. 1H NMR (400
MHz, CDCl3): 1.34 (12H, s), 3.04 (1H, s), 7.32 (1H, t, J = 7.6 Hz), 7.58 (1H, d, J = 7.6
Hz), 7.78 (1H, d, J = 7.2 Hz), 7.95 (1H, s) ppm.

13

C NMR (100 MHz, CDCl3): 24.86,

83.60, 84.02, 121.68, 127.66, 134.64, 134.89, 138.52 ppm. MS-EI: calcd for C14H17BO2:
228; found: 228.
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3.7.3

General procedure for the synthesis of azides
In a 2-neck flask, aryl bromide (1 mmol), NaN3 (2 mmol), sodium ascorbate (0.05

mmol), CuI (0.1 mmol), N,N-dimethylethylamine (0.15mmol), and 4 mL of EtOH-H2O
(7:3) were added. The flask was degassed and backfill with nitrogen, the reaction was
stirred under reflux condition and reaction was monitored by TLC. Upon completion of
reaction, the reaction was cooled down to room temperature. Reaction mixture was
diluted with water and aqeous layer was extracted with ethyl acetate (2 X 30 mL).
Organic layers were combined together and dried over MgSO4 and solvent was
evaporated. Crude mixture was purified by flash chromatography to give the desired aryl
azide.
3-Azidoaniline (12). Reaction was completed in 40 min to give 12 in 97% yield. 1H
NMR (400 MHz, CDCl3): 3.73 (2H, s), 6.31 (1H, s), 6.45 (1H, d, J = 8.0 Hz ), 7.11 (2H,
t, J = 7.6 Hz) ppm.

13

C NMR (100 MHz, CDCl3): 105.40, 109.02, 111.93, 130.61,

140.99, 148.10 ppm. MS-EI: calcd for C6H6N4: 134; found: 134.
tert-Butyl

(3-azidophenylamino)-(tert-butoxycarbonylamino)methylenecarbamate

(14). In a flask equipped with a stir bar, 1H-pyrazole-1-carboxamidine with di-tert-butyl
dicarbonate and 8 mL of CH3CN were mixed at room temperature until completely
dissolved. To the flask was added 12 and mixture was refluxed for 8 hrs. Solvent was
evaporated and crude reaction mixture was purified with flash chromatorgraphy giving
14 in 35% yield. 1H NMR (400 MHz, CDCl3): 1.51 (9H, s), 1.54 (9H, s), 6.76 (1H, s, J =
3.6 Hz), 7.27 (2H, s), 7.61 (1H, s), 10.38 (1H, s), 11.60 (1H, s) ppm.

13

C NMR (100
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MHz, CDCl3): 28.15, 28.08, 79.81, 83.98, 112.64, 115.17, 118.16, 129.97, 138.39,
140.72, 153.30, 163.29 ppm. MALDI (M+H): calcd for C17H24N6O4: 377; found: 377.
tert-Butyl 3-bromobenzylcarbamate (17).

In a flask commerically available 3-

bromobenzylamine and di-tert-butyl dicarbonate were dissolved in methanol (10 mL). To
the flask TEA was added dropwise and reaction mixture was stirred for 12 hrs. Solvent
was evaporated and crude reaction mixture was purified with flash chromatorgraphy
giving 17 in 88% yield. 1H NMR (400 MHz, CDCl3): 1.46 (9H, s), 4.29 (2H, d, J = 5.6
Hz), 4.85 (1H, s), 7.21 (2H, m), 7.40 (1H, m), 7.42 (1H, s) ppm.
CDCl3):

28.38, 122.66, 125.97, 130.15, 130.40, 141.38

13

C NMR (100 MHz,

ppm. MS-EI: calcd for

C12H16BrNO2: 286; found: 286.
tert-Butyl 3-azidobenzylcarbamate (18). General procedure for azide synthesis was
used to obtain 18 (58% yield). 1H NMR (400 MHz, CDCl3): 1.46 (9H, s), 4.30 (2H, d, J
= 5.6 Hz), 4.96 (1H, s), 6.90 (1H, s), 6.93 (1H, s), 7.05 (1H, d, J = 7.6 Hz), 7.29 (1H, t, J
= 8.4 Hz) ppm. 13C NMR (100 MHz, CDCl3): 28.39, 44.24, 79.71, 117.78, 117.89,
123.83, 129.96, 140.32, 141.19, 155.92 ppm. MS-EI: calcd for C12H16N4O2: 248; found:
248.
3.7.4. General procedure for the synthesis of trizole ring based boronic acids
Compound 10 (1 mmol) and respective azide (1 mmol) was suspended in a 1:1 mixture of
water: tert-butanol in a flask. To the flask was added sodium ascorbate (0.3 mmol,
dissolved in 0.05 mL water) followed by copper (II) sulfate pentahydrate (0.03 mmol,
dissolved in 5 µL water). The hetergoneous mixture was stirred at 80 oC until the reaction
went to completion. The reaction mixture was diluted with water and aqeous layer was
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extracted with ethyl acetate. Organic layers were combined together and dried over
MgSO4 and solvent was evaporated. The crude mixture was purified with flash
chormatorgraphy to give the desired boronic ester and boronic acid.
3-(1-(3-Aminophenyl)-1-H-1,2,3-triazol-4-yl)boronic acid (13). The reaction was
stirred for 24 hr and yield boronic ester 17 % and boronic acid in 9.6 %. Boronic ester: 1H
NMR (400 MHz, CDCl3): 1.37 (12H, s), 3.94 (N-H, 2H, s), 6.71-6.74 (1H, dd, J = 2.4,
5.6 Hz), 7.05-7.08 (1H, dd, J = 2.0, 6.0 Hz), 7.19 (1H, t, J = 2.0 Hz), 7.28 (2H, t, J = 8.0
Hz), 7.48 (1H, t, J = 7.6 Hz), 7.81 (1H, d, J = 7.6 Hz), 8.12-8.14 (1H, tt, J = 1.6 Hz), 8.21
(1H, s) ppm.

13

C NMR (100 MHz, CDCl3): 24.87 (d), 83.98, 106.91, 109.95, 115.08,

117.78, 128.39, 128.68, 129.75, 130.51, 132.07, 134.72, 147.85, 148.12 ppm. HRMS
(ESI+): calcd for C20H23BN4O2: 363.1914; found: 363.1992. Boronic acid: 1H NMR (400
MHz, CDCl3) δ: 6.78-6.82 (2H, m), 7.06-7.09 (1H, m), 7.18 (1H, t, J = 2.4 Hz), 7.23-7.28
(2H, m), 7.33-7.35 (2H, m) ppm. 13C NMR (100 MHz, CDCl3) δ: 107.74, 110.31, 113.67,
116.73, 118.33, 131.33, 131.60, 132.70, 139.24, 149.47, 150.93, 159.09 ppm. Under
mass spectrometery conditions the boronic acid was oxidized. MS (ESI-): C14H12N4O:
252; found: 252.
3-(1-(3-Guanidinophenyl)-1H-1,2,3-triazol-4-yl)boronic acid (15). The reaction was
stirred for 48 hr and yield boronic ester 8.2% and Boc protected boronic acid in 8.5%.
Boronic ester: 1H NMR (400 MHz, CDCl3): 1.37 (12H, s), 1.53 (9H, s), 1.56 (9H, s), 7.48
(2H, t, J = 7.6 Hz ), 7.62 (2H, t, J = 6.0 Hz), 7.82 (1H, t, J = 7.2 Hz), 8.14 (1H, d, J = 7.6
Hz), 8.24 (1H, s), 8.30 (2H, d, J = 4.0 Hz) ppm. 13C NMR (100 MHz, CDCl3): 24.86 (d),
28.09 (d), 83.95, 84.20, 113.87, 116.33, 117.79, 121.66, 128.36, 128.69, 129.68, 130.18,
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132.03, 134.78, 137.38, 138.34, 148.29, 153.48, 163.19 ppm. MS (ESI+): calcd for
C31H41BN6O6: 605.5; found: 605.5. Boronic acid: 1H NMR (400 MHz, CDCl3): 6.80-6.83
(1H, qq, J = 0.8, 1.6 Hz ), 7.28 (1H, t, J = 8.0 Hz), 7.35-7.37 (2H, m), 7.40-7.42 (1H, tt, J
= 1.2 Hz ), 7.69 (1H, t, J = 8.0 Hz), 7.89-7.93 (2H, m) ppm.

13

C NMR (100 MHz,

CDCl3): 112.21, 115.28, 116.71, 118.50, 118.85, 124.92, 129.75, 131.02, 131.15, 136.57,
138.10, 148.49, 156.69, 157.79 ppm. Under mass spectrometery conditions the boronic
acid was oxidized. MS (ESI-): calcd for C15H14N6O: 295.3; found: 295.2.
3-(1-(3-Aminomethyl)phenyl)-1H-1,2,3-triazol-4-yl)boronic acid (19). The reaction
was stirred for 24 hr and yield Boc protected boronic acid in 7.5% and upon deprotection
of Boc group with TFA gave the final boronic acid (19). 1H NMR (400 MHz, CDCl3):
4.28 (2H, s), 6.85 (2H, d, J = 7.6 Hz), 7.28 (1H, t, J = 8.0 Hz), 7.39 (2H, d, J = 6.8 Hz),
7.61-7.67 (2H, m), 7.98 (1H, d, J = 7.2 Hz), 8.08 (1H, s), 8.86 (1H, s) ppm.

13

C NMR

(100 MHz, CDCl3): 42.44, 107.74, 110.31, 113.67, 116.73, 118.33, 131.33, 131.60,
132.70, 139.24, 149.47, 150.93, 159.09 ppm. MALDI (M+H): calcd for C15H14N4O:
267.3; found: 267.0.
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Chapter 4. Synthesis and Structure-activity Relationship and NMR
Studies of a Series of Phenyl Alkyl ketone Analogs as Highly Potent and
Selective PDE4D2 Inhibitors
Abstract: A new series of the phenyl alkyl ketones as PDE4D2 inhibitors were
investigated. Seven compounds were identified to have sub-micromolar IC50 values.
Among them, the most potent compounds 5q, 5l, and 5g have IC50 values of 83, 170, and
200 nM respectively. Compound 5a showed lower inhibition activity of 45 µM, but better
selectivity (22 fold) over other PDE families (PDE9A2, HisPDE2A3, and PDE5A1)
except for PDE7A1 when compared to genistein. Compound 5b had similar inhibition
activity as genistein but showed preference for PDE4D2 with selectivity of 285, 285, 142,
and 42-fold over PDE7A1, PDE9A2, HisPDE2A3 and PDE5A1 respectively. Transfer
NOESY studies indicated that the free 5e and the bound inhibitor with PDE4D2 may
have the same conformation.
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4.1.

Contributions
The goal of this project was to synthesize a new class of PDE4 enzyme inhibitors.

Earlier designed PDE4 enzyme inhibitors have shown promising results but have
therapeutic limitations due to their does-limiting side effects such as nausea and emesis.
Such limitations arise from their poor selectivity among the different PDE families.
Herein we have focused on the design and synthesis of novel enzyme inhibitors to target
the subfamily of PDE4, i.e. PDE4D to enhance selectivity among families and reduce the
side effects. Totally, 41 inhibitors were synthesized, among which 23 were synthesized
by Dr. Shilong Zheng. Compounds that I have synthesized will be described further with
their synthesis and inhibition activity and selectivity.
Dr. Ke at University of North Carolina carried out the inhibition assays and
calculated the IC50 values. NMR studies were carried out by Dr. James Prestegard at
University of Georgia. Molecular modeling on binding profile of inhibitors was carried
by Dr. Minyong Li.
4.2.

Introduction
Four decades ago, Sutherland and Rall first reported the hydrolytic activities of

cyclic nucleotide phosphodiesterases (PDEs). They reported that PDEs can hydrolyze
adenosine and guanosine 3´, 5´-cyclic monophosphates (cAMP and cGMP) to 5´-AMP
and 5’-GMP in a variety of tissues1 (Figure. 4.1). The second messengers cAMP and
cGMP mediate the response of cells to a wide variety of hormones and neurotransmitters,
and modulate many biological and metabolic processes, such as cardiac and smooth
muscle contraction, platelet aggregation, secretion, apoptosis, and growth control.2-8
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Intracellular cAMP and cGMP are synthesized respectively by adenylyl cyclase and
guanylyl cyclase, 6 and hydrolyzed by PDEs.
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Figure 4.1. PDE- catalyzed hydrolysis of cAMP and cGMP
The human genome encodes twenty one PDE genes that are categorized into
eleven families and subdivided into over sixty PDE isoforms. The discovery of PDEs
families was first made during a study conducted from the crude tissue extracts eluted
from the anion exchange column. Different fractions collected from the column indicated
at least one kinetically distinct PDE and more significantly the amounts of PDE differ
among various tissues.9 Such a discovery led to the proposal of developing new selective
inhibitors that could target specific diseases. Theophylline (1), a non selective PDE
inhibitor, has been used for the treatment of asthma and other pulmonary diseases. The
non-selective nature of theophylline not only produces side effects but also limits its use
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in selectively inhibiting particular PDE in target tissues.1 With the discovery of PDE
families and some twenty crystal structures of PDEs available,10 selective inhibitors of
PDEs have been synthesized and studied as therapeutics for treatment of various human
diseases. Successful examples include PDE5 (PDE family 5) inhibitors sildenafil
(ViagraTM), vardenafil (LevitraTM), and tadalafil (CialisTM) for treatment of erectile
dysfunction. PDE4 inhibitors have shown great potential for treatment of asthma and
chronic obstructive pulmonary disease, but side effects such as emesis prevent their
practical applications. It is generally believed and hypothesized that side effects of PDE4
inhibitors arise from inhibition of non-targeted PDE families or lack of selectivity against
subfamilies PDE4A, B, C, and D.

However, the molecular basis for family and

subfamily selectivity of PDE4 inhibitors is poorly understood. This study was aimed at
the design and synthesis therapeutically useful PDE4 subfamily inhibitors.
The nomenclature of the PDE families is as follow: Most families include more
than one gene and sometimes numerous splice variants. Nomenclature of PDEs includes
gene family designation (PDE isozyme 4) followed by the gene product (PDE4D) and
lastly the splice variant (PDE4D2)
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The homology of PDEs is categorized into three regions: conserved catalytic domain,
the N-terminal, and the C-terminal region (Figure 4.3). The catalytic domain of all 11
families of PDE shares about 30 to 50% of amino acids. The C-terminal domain
functions are unclear however the N-terminal region regulates various functions in PDEs.
For example, in PDE2, the N-terminal contains the cGMP binding site whereas it has
phosphorylation sites for various protein kinases in PDE1, PDE3, PDE4, and PDE5.1 All
PDEs contain a conserved catalytic domain, but each family possesses different substrate
specificities and selective inhibitors. PDE 4, 7, and 8 prefer to hydrolyze cAMP while
PDE 5, 6, and 9 are cGMP-specific. PDE 1, 2, 3, 10, and 11 enzymes show activity
toward both nucleotides.10 The conservation of the catalytic domain among the families
predicts that the families would also share the same inhibitors. Indeed it has been
reported that a selective inhibitor of PDE5, Viagra, has IC50 of 3.5 nM and it also shows
inhibition for PDE4 with IC50 of 7.7 µM.11
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Variable
COOH

Different domains of PDEs1

4.4.1. Crystallographic data of PDEs
Crystal structures of PDEs typically contain a compact arrangement of 16 α helices
which are arranged in three subdomains. An example of PDE crystal structure is shown
in Figure 4.4, where the binding site domains are shown in blue and green colors.12 The
active site of enzyme consists of deep hydrophobic pocket located at the intersection of
the three subdomains. The binding site domain consists of four regions: a) metal binding
site (M), b) core pocket (Q), c) hydrophobic pocket (H), and d) lid region.10 At the time
of writing crystal structures of five families have been reported: PDEs 1, 3, 4, 5, and 9.
Since the focus of this study is on PDE4, only crystal structures of PDE4 subfamilies will
be discussed. The crystal structure of PDE4D shows a tetrameric formation, however a
dimer for PDE4D has been proposed as the catalytic form based on crystal structure of
PDE4D with zardavarine (PDED 4 inhibitor).12 While PDE4B catalytic domain is a
monomer, PDE4A have various oligomerization states from monomer, dimer, to
tetramer. Aside from their distinct conformational states, the subtypes of PDE4 have
distinct tissue and cellular distribution as well. Several studies have shown that the
PDE4C is abundant in the neuronal tissue but absent in the inflammatory and immune
cells.13, 14 PDE4A has been shown to be distributed evenly in tissues1 and PDE4B is
expressed in heart, brain, skeletal muscle, and lung.15 The N-terminal of PDE4A also
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influences inhibitor potency for some of the PDE4 inhibitors. For example, a careful
examination of PDE4A4 has shown that it coexists in two conformational states and
rolipram (2), a known PDE4 inhibitor, prefers to bind one conformer over the other.
Upon deletion of N-terminus the potency of rolipram is reduced by 10- to 30-fold.16-18 In
a similar example, the N terminal of PDE4D3 is a site for phosphorylation. The
phosphorylation activates one conformer over the other of PDE4D3 and studies have
indicated that rolipram binds to the phosphorylated conformer with higher affinity than
the non phosphorylated conformer.18, 19

Figure 4.4. Surface plot of the crystal structure of PDE4D2. Blue indicates binding
pocket hydrophilic areas and green hydrophobic areas. Binding subdomains are: core
region (Q), metal region (M), and hydrophobic region (H).10
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4.4.2. Design of new PDE4 inhibitors based on crystallographic data of rolipram
The complex structure of PDE4D2-rolipram showed that the binding residues for
PDE4 inhibitor rolipram is absolutely conserved in the PDE4 subfamilies, thus
suggesting that the subfamily selectivity is largely dependent on their conformational
states.12 The derivatives of rolipram account for a large percentage of the PDE4 inhibitors
known and show encouraging results in clinical trials for treatment of asthma and chronic
obstructive pulmonary disease (COPD). Roflumilast (3) is the best representative of these
compounds and has been filed for Investigative New Drug application (IND) as a drug
for COPD and asthma. Thus we synthesized our general-PDE4 selective inhibitors based
on the rolipram core. Co-crystallized structure of the rolipram (2) with enzyme reveals
that it forms two hydrogen bonds with the side chain of Gln369 and many hydrophobic
interactions with the active site (Figure 4.5). The cyclopentyloxy group of rolipram
occupies the hydrophobic pocket thus hydrophobic substitution can be made with groups
such as a cyclopentane ring in new inhibitor design. The phenylmethoxy ring sits in the
ditch shaped pocket. Thus only a planar ring can be used for the new PDE4 inhibitor. The
methoxy group of the phenylmethoxy occupies the opening space. This open space has a
little extra space for a slightly bigger group either polar or nonpolar to be substituted. The
pyrrolidone ring does not make any significant interactions with the catalytic site; rather
it is open to the adjacent metal pocket. Thus dramatic changes can be made to the
pyrrolidone ring.12
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Figure 4.5. The key residues in the binding site of Rolipram to PDE4D2 X-ray
model (PDB entry: 1OYN). The residues are represented as line and rolipram is
shown in stick and ball. H-bond is represented as green line and distance (Å). The
hydrogen atoms were removed for clarity.
4.5.

Chemical synthesis of novel PDE4 inhibitors

Earlier studies have indicated that the alkoxy group in both 3 and 4 position are
needed.20 So in our designed analogs, various heteroatom based alkoxy groups were
substituted on the 3-position via alkylation of 1 and 2a-2b (Scheme 4.1). Alkylation of
3,4-dihydroxybenzaldehyde using chlorodifluoroacetate in the presence of CsCO3
provided 4-difluoromethoxy-3-hydroxy benzaldehyde 2a in 50% and 3,4bis(difluoromethoxy)benzaldehyde 2b as side product. The commercially available 3hydroxy-4-methoxybenzaldehyde 2c and 4-difluoromethoxy-3-hydroxy-benzaldehyde 2a
were reacted with various racemic alcohols (R2OH) in THF via Mitsunobu reaction to
100

give racemic aldehydes 3a-e in 38-40% yield. Treatment of aldehydes (3a-e) with either
n-butyllithium, t-butyllithium or Grignard reagent gave the corresponding diastereomeric
mixture of alcohols 4a-o. The oxidization of the alcohol with PCC afforded the
corresponding ketones 5a-o.

OCHF2

OH

OH

HF2CO
+
CHO

HF2CO

CClF2COOMe

HO

Cs2CO3/ DMF
CHO

2a

1

OH
R1O
CHO
2a: R1 = -CHF2
2c: R1 = -CH3

2b

OR2

O

3a: R1 = CHF2, R2 =

R1O

R2OH/PPh3/THF

CHO

NBoc

3b: R1 = CHF2, R2 =

t-BuO2CN=NCO2Bu-t

O

CHO 3c: R1 = CH3, R2 =
3a-e

3d: R1 = CH3, R2 =

O

3e: R1 = CH3, R2 =
OR2
R3Li or R3MgBr
THF, -78 oC

NBoc

OR2

R1O

PCC/DCM

R1O

R3
4a-o OH

R3
5a-o

O

Scheme 4.1. Synthesis route to phenyl alkyl ketones
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4.6.

Structure activity relationship (SAR) of PDE4D inhibitors
The enzyme inhibitory activities of the synthesized compounds were evaluated

against human PDE4D2 which had been cloned and expressed in E. coli strain BL21
(Codonplus). The results are summarized in Table 4.1 and 4.2. Table 4.1 also includes
compounds (entries 1-4) that were synthesized by Dr. Shilong Zheng for comparison
purposes and for the discussion of SAR
In Table 4.1, a few of the intermediates were tested along with the final
compounds for their inhibition activity and it was found that the phenyl alkyl methanols
(entries 1-2, 4) were 2 ~150 folds less potent than the corresponding phenyl alkyl ketones
(entries 5-25). The 3-methoxy substituted phenyl compounds (entry 4) were 20 ~ 150
fold more potent than the corresponding 4-methoxy substituted compounds (entries 1-3).
From the initial SAR results it was concluded that the new series of compounds should be
substituted with 3-methoxy substitutent and that the ketones have higher inhibition
activity than their corresponding alcohols (entry 2 and 3)
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Table 4.1. IC50 (µM) values of PDE4D2 phenyl alkyl methanols and phenyl alkyl
ketones
inhibitors
O

R2

R2

O

R1O

R1O

R3
OH

Entry
1

Compd

R3
OR

O

R1

4a

R2

R3

IC50 (µM)

-CH3

n-Pr

1500

O

-CH3

n-Pr

520

O

-CH3

n-Pr

24

n-Bu

10

O
O

O

O
OH

2

4b

O
O
O
OH

3

4c

O
O
O
O

4

4d

O

-CH3

O

O
O

OH

Table 4.2 shows the new series of compounds that were synthesized after the
initial round of testing. The tetrahydrofuran-3-yloxy substituted phenyl compounds
(entries 12-13) have 1.3 ~ 8.5 fold better activity than the corresponding tetrahydropyran3-yloxy substituted phenyl compounds (entries 8-9). Upon chaging the tetrahydropyran
ring to piperidine ring, both compounds 5d and 5e, the Boc protected piperidi-4-nyl (IC50
4.8 µM) and the deprotected piperidi-4-nyl substituted (IC50 102 µM) (entries 10 and 11)
lost their activity and were 2 fold less active than the corresponding tetrahydropyran-3-
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yloxy substituted phenyl compounds. Compared to the Boc protected compound (5d) the
deprotected compound 5e has lower inhibition activity.
In the series of the 4-methoxy-3-tetrahydrofuran-3-yloxy phenyl ketones (entries
12-20), the ketone with i-butyl side chain has the best activity (IC50 176 nM) and the
ketone (entry 13) with the n-butyl side chain has the second best activity (IC50 200 nM).
Upon increasing the side chain length for 5m, the activity was lost (IC50 380 nM). The
activity of ketones (entries 16 and 17) with a cyclohexylalkyl chain and a phenylalkyl
chain (entries 14 and 15) consistently showed the weakest activity. The replacement of
tetrahydrofuran ring with the Boc protected tetrahydropyrrol (entries 21 and 22)
decreased the activity to 380 nM and 30 µM, respectively. Again, among the Boc
protected terahydropyrrol compounds (entries 21 and 23), the compound with i-butyl side
chain had better activity (IC50 380 nM) compared to its analog with n-butyl side chain
(IC50 30 µM). Upon deprotecting the Boc group, the n-butyl side chain analog of
tetrahydropyrrol series had better activity (IC50 1 µM, entry 22). However the acetyl
protected tetrahydropyrrol gave the best activity with IC50 of 83 nM.
From the above SAR studies, ketones with alkyl chains and 3-tetrahydrofuran-3yloxy group gave good activity. However upon substituting the 3-tetrahydrofuran-3yloxy group with 3- acetyl protected tetrahydropyrrol the inhibition activity improved
with IC50 of 83 nM which turned out to be the best inhibitor among the series of
compounds synthesized.
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Table 4.2. IC50 (µM) values of PDE4D2 phenyl alkyl ketones inhibitors

O

R2

R1O
R3
O

Entry

Compd

7

5a

R1

R2

-CH3

O

R3

IC50 (µM)

3-quinoline

45

n-Pr

3.5

n-Bu

0.72

n-Bu

4.8

n-Bu

102

n-Pr

0.4

O
O
O

N

O

8

5b

O

-CH3
O

O
O

O

9

5c

O

O

-CH3
O

O

O

10

5d

N Boc

O

-CH3
N

Boc

O

O

11

5e

NH

O

-CH3
H

O

N

O

12

5f

O
O

-CH3

O

O

O
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13

5g

O

-CH3

O

-CH3

O

O

n-Bu

0.2

-(CH2)3Ph

2.3

-(CH2)2Ph

2.6

(CH2)2cyclohexyl

1.9

-CH2-cyclohexyl

2.6

i-Bu

0.176

i-pen

0.380

t-Bu

0.410

O

O

14

5h

O
O
O
Ph
O

15

5i

-CH3

O
O

O

O
Ph
O

16

5j

-CH3

O
O

O

O

O

17

5k

O

-CH3

O

O

O

O

18

5l

-CH3

O

O

O
O

O

19

5m

O

-CH3

O

O
O

O

20

5n

O

-CHF2

O

O
HF2C

O

O
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21

5o

Boc
N

-CHF2

Boc-N

n-Bu

30

n-Bu

1.0

i-Bu

0.083

O
HF2C

O

O

22

5p

H
N

-CHF2

N

O
HF2C

O

O

23

5q

O
N

-CHF2

O
N

O
HF2C

O

O

Two representatives of the found PDE4D2 inhibitors were tested in human
PDE7A1, 9A2, 2A3 and 5A1 subtypes , which had been cloned and expressed in E. coli
strain BL21(Codonplus) (Table 4.3). Compared with the low selectivity of Genistein,
most of our compounds showed interesting PDE4D2 subtype specificities. For example,
5a had lower inhibition activity but showed preference for PDE4D2 with selectivity of
11, 22, 22, and 22 fold over PDE7A1, PDE9A2, HisPDE2A3 and PDE5A1 respectively.
Compound 5b had similar PDE4D2 inhibitory activities (IC50 3.5 µM) compared with
Genistein (IC50 3.2 µM), however, its selectivity over PDE7A1, PDE9A2, HisPDE2A3
and PDE5A1 was 14, 14, 12, and 5-fold higher than that of genistein, respectively.
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Table 4.3. IC50 values (µM) of selected inhibitors with various PDEs

PDE4D2

PDE7A1

PDE9A2

HisPDE2A3

PDE5A1

(79-438)

(130-482)

(181-506)

(580-941)

(535-860)

Genistein

3.2

70

70

40

30

5a

45

500

1000

1000

1000

5b

3.5

1000

1000

500

150

IC50(µM) is about 1000 µM means no less of activity with 100 µM inhibitors

Among the 23 inhibitors that were synthesized, 7 inhibitors had better activity
than rolipram (1µM). Selective inhibitors (5m, 5n, and 5q) were overlayed with rolipram
(Figure 4.6) in the active site of the enzyme to study the conformation of inhibitors to the
rolipram. All the three inhibitors 5m (yellow), 5n (green), and 5q (blue) occupied the
same binding pockets compared to rolipram (red) but with different conformation.
Compared to the rolipram the three inhibitors had the alkyl chains extending towards the
metal pocket compared to pyrrolidone ring of the rolipram, the closer proximity of the
new inhibitors towards the metal pocket could have led to enhanced inhibition activity of
the inhibitors.
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Figure 4.6. Overlay of the inhibitors 5m (yellow), 5n (green), and 5q (blue) with
rolipram into the PDE4D2 crystal

4.7.

NMR study of the interaction of 5e with PDE4D2 protein

The interactions of inhibitor 5e with PDE4D2 were studied with NMR. Saturation
transfer difference (STD) and transfer nuclear Overhauser effect (trNOE) experiments
were performed to demonstrate binding between PDE4D2 and the inhibitor 5e. The
binding epitope of the inhibitor was also determined. The solubility of 5e up to 800 µM
in D2O was confirmed by NMR. A reference 1H spectrum allowed assignment of
resonances as indicated in Figure 4.7. A 2D NOESY spectrum was also obtained for the
5e (Figure 4.8).
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Figure 4.7. A reference and assignment of 1H spectrum of 400 µM 5e. The water peak
in the center of the spectrum was removed for clarity. Note: Peak ‘i’ was not assigned
and is believed to be a contaminant.

Figure 4.8. A 2D NOESY spectrum of 400 µM 5e with 500 ms mixing time. Blue
indicates positive peaks and red indicates negative peaks. The crosspeak intensities are
negative indicating positive NOE’s typical of small molecules free in solution.
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The 800 µM STD spectrum of 5e with the PDE4D2 shows changes in the
spectrum (Figure 4.9). The different distribution of peak intensities can be seen as
compared to the reference spectrum. For example, peak ‘d’ is depressed and peak ‘n’
enhanced relative to other peaks. This is due to close contact of protons assigned to these
peaks with protons of the protein.
The trNOEsy spectra obtained are shown in Figure 4.10. The changes in signs were
observed for the cross peaks relative to those in the reference NOESY spectra. This is
indicative of dominance by the slowly tumbling bound form of the inhibitor. The
appearance of similar cross peak sets to those seen in the reference NOESY spectrum is
indicative of some similarity in the bound form as compared to the solution form of the
inhibitor.

Figure 4.9. A STD spectrum of 800 µM 5e and 10 µM PDE4D2. The protein was
selectively saturated at 0.5 ppm with 250 ms of saturation. The protein background was
not subtracted or suppressed. The water peak was removed for clarity.
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(a)

(b)

Figure 4.10. 2D NOESY spectra of 800 µM 5e and 10 µM PDE4D2 with (a) 50 ms and
(b) 300 ms mixing times. The crosspeaks have positive intensities (i.e. negative NOE’s)
which indicate that 5k is binding PDE4D2.
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Compound 5e and PDE4D2 provide a near ideal system for the NMR study. The
solubility of 5e was high enough to prepare a sample for NMR detection, and the
exchange rate with the protein was fast enough to perform STD and trNOE experiments.
The binding epitope and interesting NOE’s were observed. The peaks for 5e in STD and
NOESY spectra were assigned using the 1H reference spectrum. The peak integrals from
the reference and STD spectrum were compared and normalized to give a STD
percentage for each proton (Figure 4.11). The STD percentages give an indication of
which protons of bound 5e are close to the protein, i.e. an epitope map. For 5e, peak ‘i’
was not observed in the STD indicating that it does not bind PDE4D2 providing evidence
that it is a contaminant. Non-specific binding was not observed for 5e at the
concentrations studied as evidenced by the STD of the diluted sample which showed a
similar pattern of enhancements (data not shown).

Figure 4.11. The STD percentage for each proton is shown for the 5e.
NOESY spectra also gave useful information about the binding and structural
conformation of small molecules. When compared to the reference NOESY spectrum of
the inhibitor, the transferred NOESY spectrum of the inhibitor in the presence of the
protein can indicate binding.

Small molecules exhibit positive NOE’s and large
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molecules have negative NOE’s. When a small molecule binds to a large molecule, such
as a protein, its properties change and negative NOE’s are observed. For 5e, positive
NOE’s are observed for the sample of the inhibitor alone (Figure 4.8) and negative
NOE’s are observed for the samples in the presence of PDE4D2 (Figure 4.10). These
results corroborate the STD results that 5e binds to PDE4D2. Moreover, transferred
NOESY spectra can provide information about the conformation of the bound inhibitor.
The relative intensities of the NOESY crosspeaks can be used to calculate distances
between protons.

Qualitative information can be readily determined by looking at

crosspeaks in the 50 ms transferred NOESY spectrum of 5e in the presence of PDE4D2
(Figure 4.10a). For example, the crosspeaks observed from the aromatic protons show
that peaks ‘a’ and ‘b’ are close in space to the methylene group, ‘g’, and peak ‘c’ is close
to the methyl group, ‘d’. In addition, peak ‘b’ is close to peaks ‘j’ and ‘k’ and to water.
All of these interactions are also observed in the NOESY spectrum of the free inhibitor
(Figure 4.8) indicating that the free and bound conformation may be the same. The NOE
to the water molecule in the transferred NOESY spectrum indicates that water is
accessible to the inhibitor in the bound state, demonstrating that water is in the binding
pocket with the inhibitor or the bound state inhibitor is solvent-accessible on the side of
the molecule.
4.8.

Conclusions
A new series of the phenyl alkyl ketones as PDE4D inhibitors were investigated.

Seven compounds were identified as having sub-micromolar IC50 values. Among them,
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the most potent compounds 5q, 5l, and 5g have IC50 values of 83, 170, and 200 nM,
respectively. Compound 5a showed lower inhibition activity of 45 µM, but better
selectivity (22 fold) over other PDE families (PDE9A2, HisPDE2A3, and PDE5A1)
except for PDE7A1 when compared to genistein. Compound 5b had similar inhibition
activity as to genistein but showed preference for PDE4D2 with selectivity of 285, 285,
142, and 42-fold over PDE7A1, PDE9A2, HisPDE2A3 and PDE5A1 respectively.
Comparison of STD experiments of both free and bound inhibitor indicated that the
methyl group of the butyl side chain was in close contact with the protein. Also the
intensity of the methyl of methoxy group decreased in the bound form indicating binding
to the protein. Transferred NOESY studies indicated that free 5e and the bound inhibitor
with PDE4D2 may have the same conformation, since the cross peaks observed from the
aromatic protons matched the cross peaks observed in the free inhibitor. Cross peaks
observed also showed that α methylene group and methoxy group were closer to the
aromatic protons. It was also indicated that one of the aromatic proton was accessible to
the water molecule in the binding pocket.
4.9.

Experimental

4.9.1. General chemistry
All reagents were purchased from Acros and Aldrich. N-(t-butoxycarbonyl)-4piperidinol was synthesized according to the procedure1. Microwave heating was
performed in the single-mode microwave cavity of a Discover Synthesis System (CEM
Co.), and all microwave-irradiated reactions were conducted in a heavy-walled glass vials
sealed with Teflon septa. 1H-NMR and

13

C-NMR were recorded at 400 and 100 MHz,
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respectively, on a Bruker 400 NMR spectrometer. Combustion analyses and mass spectra
were performed by the analytical and the mass spectrometry facilities at Georgia State
University. Molecular modeling on binding profile of inhibitors was carried by Dr.
Minyong Li. The inhibition constants (IC50), the inhibitor concentration that produces
50% enzyme inhibition in the presence of substrate [S], were determined by Dr.
Hingming Ke at University of Chapel Hill.
4.9.2. Determing Inhibiton Constants (IC50)
The inhibition constants (IC50), the inhibitor concentration that produces 50%
enzyme inhibition in the presence of substrate [S], were determined by equation 1. The
activity of the substrates, cAMP and cGMP, were measured at eight different
concentration and each measurement was repeated three times. Vmax and Km values were
calculated by linear plot of Eadie-Hofstee (V/[S] vs. V) where V is velocity of reaction
and [S] is concentration of substrate. In the linear plot the y intercept is equivalent to Vmax
and slope is equal to -Km. The apparent inhibition constants (Kapp) were measured with
LineWeaver-Burt plot in the presence of the inhibitors. The Ki values of the inhibitors
were obtained form the plot of Kapp versus inhibitor concentration.

IC 50 = (1+ [S]/Km) Ki

Equation 1
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4.9.3. Preparation of 4-Difluoromethoxy-3-hydroxybenzaldehyde (2a) and 3,4Bisdifluoromethoxybenzaldehyde (2b)
A mixture of 3,4-dihydroxybenzaldehyde (1.38 g, 0.01 mol), methyl chlorofluoroacetate
(1.87 g, 0.013 mol) and cesium carbonate (4.24 g, 0.013 mol) in DMF (20 mL) was
stirred at 65 °C for 3 h under an nitrogen atmosphere, then DMF was removed in vacuo
and the residue was portioned between aqueous 3N HCl and ether. The aqueous layer
was extracted three times with ether. The combined organic solution was washed with
water and brine, dried over MgSO4, filtered and evaporated. The residue was purified by
flash chromatography to afford 2a as a white solid (0.85 g, 45%) and 2b as a yellowish
liquid (0.48 g, 20%). (2a). 1H NMR (400 MHz, CDCl3): 6.17 (1H, s, br), 6.67 (1H, t, J =
72.8 Hz), 7.28 (1H, d, J = 8.4 Hz), 7.45 (1H, dd, J = 4.0 and 8.4 Hz), 7.55 (1H, d, J = 4.0
Hz), 9.92 (1H, s) ppm. 13C NMR (CDCl3): 115.6 (triplet, J = 262 Hz, d), 117.1 (d), 119.3
(d), 123.2 (d), 134.5, 143.0, 147.8, 191.1 (d) ppm. MS (EI): calcd for C8H6F2O3 (M+):
188; found 188. (2b). 1H NMR (400 MHz, CDCl3): 6.63 (1H, t, J = 72.8 Hz), 6.68 (1H, t,
J = 72.4 Hz), 7.43 (1H, dd, J = 8.8 Hz), 7.79 ~7.77 (2H, m), 9.95 (1H, s) ppm. 13C NMR
(100 MHz, CDCl3): 115.3 ((d)t, J = 262 Hz), 115.5 ((d)t, J = 263 Hz), 121.4 (d), 128.7
(d), 134.1, 142.3, 147.1, 190.1 (d) ppm. MS (EI): calcd for C9H6F4O3 (M+): 238; found
238.
4.9.4. General Procedure for the Synthesis of 3 by Mitsunobu Reaction of 2a and 2c
with R2OH
To the mixture of compounds 2 (1 mmol), R2OH (1.1 mmol) and di-tert-butyl
azodicarboxylate (1.2 mmol) in THF (5 mL), was added dropwise triphenylphosphine
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(1.2 mmol) in THF (5 mL) at 0 °C. The resulting solution was stirred until the compound
2 consumed completely (usually for 24 h). The solvent was removed in vacuo and the
residue was purified by flash chromatography to afford the product 3.
4-Difluoromethoxy-3-(tetrohydro-furan-4-yloxy)-benzaldehyde (3a) Yield: 84%. 1H
NMR (400 MHz, CDCl3): 2.19 (1H, m), 2.30 (1H, m), 3.91-4.06 (4H, m), 5.07 (1H, m),
6.67 (1H, t, J = 74.4 Hz), 7.33 (1H, d, J = 8.4 Hz), 7.44 (1H, d, J = 1.6 Hz), 7.48 (1H, dd,
J = 1.6 and 8.4 Hz) 9.93 (1H, s) ppm. 13C NMR (CDCl3): 32.7 (t), 67.0 (t), 72.5 (t), 78.8
(d), 112.9 (d), 115.5 ((d) t, J = 260 Hz), 122.2 (d), 125.2 (d), 134.3, 145.6, 149.4, 190.5
(d) ppm. MS (EI): calcd for C12H12F2O4 (M+):258; found 258.
tert-Butyl 3-(2-(difuloromethoxy)-5-formylphenoxy)pyrrolidine-1-carboxylate (3b).
Yield: 26%. 1H NMR (400 MHz, CDCl3): 1.46 (9H, s), 2.20 (2H, d, J = 7.6 Hz), 3.653.49 (4H, m), 5.01 (1H, s), 6.59 (1H, (d)t, J = 74 Hz), 7.32 (1H, s), 7.45 (1H, s), 7.49
(1H, d, J = 8.4 Hz), 9.26 (1H, s) ppm.

13

C NMR (100 MHz, CDCl3): 28.46, 31.53 (d),

44.00 (d), 51.47 (d), 79.72 (d), 113.54 (d), 122.53 (d), 125.64, 154.54, 190.55 ppm.
HRMS (ESI+): calcd for C13H13F2NO5 (M+-t-butyl) : 302.0840; found: 302.0823.
4-Methoxy-3-(tetrahydro-pyran-4-yloxy)-benzaldehyde (3c). Yield: 52%. 1H NMR
(400 MHz, CDCl3): 1.84 – 1.86 (2H, q, J = 4.4, 4.4 Hz), 2.06 (2H, d, J = 8.8 Hz), 3.57
(2H, t, J = 9.2 Hz), 3.95 (3H, s), 4.05 (2H, m), 4.51 (1H, m), 7.01 (1H, d, J = 8.4 Hz),
7.44 (1H, s), 7.47 – 7.49 (1H, q, J = 1.6, 6.4 Hz) 9.84 (1H, s) ppm. 13C NMR (100 MHz,
CDCl3): 31.86, 56.16, 65.31, 73.49, 111.25, 113.92, 127.15, 129.99, 147.09, 156.06,
190.80 ppm. HRMS (ESI+): calcd for C13H16O4 : 237.1127; found: 237.1121.
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4- Methyoxy-3-(tetrahydro-furan-3-yloxy-benzaldehye (3d). Yield: 40%. 1H NMR
(400 MHz, CDCl3): 2.25 (2H, q, J = 6.0, 8.0 Hz ), 3.94 (4H, d, J = 12 Hz), 4.04 (3H, d, J
= 2.4 Hz), 5.02 (1H, s), 7.00 (1H, d, J = 8.0 Hz), 7.35 (1H, s), 7.48 (1H, q, J = 2.0, 6.4
Hz), 9.84 (1H, s) ppm. 13C NMR (100 MHz, CDCl3): 32.98, 56.16, 67.72, 72.91, 78.67,
111.07, 112.18, 127.21, 129.96, 147.58, 155.56, 190.73 ppm. HRMS (ESI+): calcd for
C12H14O4 : 223.0970; found: 223.0965.
4-(5-Formyl-2-methoxy-phenoxy)-piperidine-1-carboxylic acid-tert-butyl ester (3e).
Yield: 53%. 1H NMR (400 MHz, CDCl3): 1.47 (9H, s), 1.80 (2H, q, J = 3.2, 3.6 Hz),
1.95(2H, q, J = 4.0, 4.8 Hz), 3.30 (2H, m), 3.80 (2H, s), 3.94 (3H, s), 4.52 (1H, s), 7.01
(1H, d, J = 8.0 Hz), 7.44 (1H, s), 7.49 (1H, d, J = 8.0 Hz), 9.84 (1H, s) ppm. 13C NMR
(100 MHz, CDCl3): 28.45, 30.61, 56.17, 74.20, 79.62, 111.26, 114.11, 127.21, 130.04,
147.16, 154.78, 156.13, 190.79 ppm. HRMS (ESI+): calcd for C18H25NO5: 336.1811;
found: 336.1814.
4.9.5. General Procedure for the Synthesis of 4 by Nucleophilic Addition to the
Aldehydes 3
To aldehyde 3 (1 mmol) in THF (5 mL), was added dropwise the n-butyllithium
or Grignard reagent at -78 °C. The resulting mixture was stirred overnight at -78 °C to rt
and quenched with water. The aqueous layer was extracted three times with ethyl acetate.
The combined organic solution was dried over MgSO4, filtered and evaporated. The
residue was purified by flash chromatography to afford 4
.1-[4-Methoxy-3-(tetrahydro-pyran-4 yloxy)-phenyl]-butan-1-ol (4b). Yield 60%. 1H
NMR (400 MHz, CDCl3): 0.92 (3H, t, J = 7.6 Hz), 1.44 (3H, m), 1.68 (1H, m), 1.87 (4H,
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m), 2.01 (2H, m), 3.56-3.51 (2H, dd, J = 2.4, 8.8 Hz), 3.84 (3H, s), 4.03 (2H, m), 4.44
(1H, m), 4.59 (1H, s), 6.86 (1H, d, J = 8.4 Hz), 6.92 (1H, d, J = 8.4 Hz), 6.95(1H, s)
ppm.

13

C NMR (100 MHz, CDCl3): 13.97, 19.10, 32.12, 41.24, 56.05, 65.38, 73.80,

73.96, 112.10, 115.34, 119.66, 137.75, 146.40, 150.28 ppm. HRMS (ESI+): calcd for
C16H22O3 -H2O: 263.1647; found: 263.1645.
1-[4-Methoxy-3-(tetrahydro-pyran-4-yloxy)-phenyl]-pentan-1-ol (4c). Yield 72%. 1H
NMR (400 MHz, CDCl3): 0.88 (3H, t, J = 6.8 Hz ), 1.25 (1.32 (3H, m), 1.65 (1H, m),
1.85 (4H, m), 2.01 (2H, s), 3.53 (2H, t, J = 8.8 Hz), 3.84 (3H, s), 4.01 (2H, t, J = 5.6 Hz),
4.43 (1H, d, J = 4.0 Hz), 4.57 (1H, s), 6.86 (1H, d, J = 8.4 Hz), 6.92 (1H, d, J = 8.4 Hz),
6.95 (1H, s) ppm. 13C NMR (100 MHz, CDCl3): 14.03, 22.58, 28.05, 32.10, 38.81, 56.02,
65.34, 73.76, 74.14, 112.09, 115.40, 119.69, 137.83, 146.35, 150.24 ppm.

HRMS

(ESI+): calcd for C17H27O4– H2O: 277.1804; found: 277.1795.
4-[5-(1-Hydroxy-pentyl)-2-methoxy-phenoxy]-piperidine-1-carboxylic

acid

tert-

butyl ester (4d). Yield 84%. 1H NMR (400 MHz, CDCl3): 0.95 (3H, t, J = 7.2 Hz), 1.44
(2H, q, J = 7.2, 7.6 Hz), 1.47 (9H, s) 1.69 (4H, m), 1.73 (2H, s), 1.92-1.96 (2H, m), 2.91
(2H, t, J = 7.2 Hz), 3.23-3.29 (2H, m), 3.80 (2H, m), 4.63 (1H, s), 3.91 (3H, s), 4.50-4.51
(1H, m), 4.70-4.72 (1H, s), 6.92 (1H, d, J = 8.4 Hz), 7.57 (1H, d, J = 2 Hz), 7.60-7.63
(1H, dd, J = 2, 6.4 Hz) ppm. 13C NMR (100 MHz, CDCl3): 14.03, 22.59, 28.06, 28.45,
30.83, 38.79, 56.04, 74.28, 74.53, 79.52, 112.13, 115.49, 119.75, 137.72, 146.47, 150.37,
154.84 ppm. HRMS (ESI+): calcd for C18H25NO4 - (H2O+ t-butyl): 320.1862 found:
320.1882
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1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-butan-1-ol (4e). Yield 40%. 1H
NMR (400 MHz, CDCl3): 0.92 (3H, t, J = 7.2 Hz), 1.30 (1H, dd, J = 6.4, 9.6 Hz), 1.42
(1H, d, J = 7.2 Hz), 1.63 (1H, s), 1.81 (2H, bs), 2.19 (2H, m), 3.84 (2H, s), 3.90 (2H, s),
4.00 (3H, s), 4.60 (1H, s), 4.97 (1H, s), 6.89 (3H, m) ppm. 13C NMR (100 MHz, CDCl3):
13.97, 19.08, 33.07, 41.24, 56.08, 67.22, 73.01, 74.07, 78.88, 112.05, 113.66, 119.33,
137.68, 146.89, 149.70 ppm. HRMS (ESI+): calcd for C15H23O4– H2O: 249.1491; found:
249.1480.
1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-pentan-1-ol (4f). Yield 41%. 1H
NMR (400 MHz, CDCl3): 0.88 (3H, t, J = 6.4 Hz), 1.22-1.35 (4H, m), 1.65-1.77 (2H, m),
1.86 (1H, s), 2.18 (2H, d, J = 5.6 Hz), 3.84 (2H, s), 3.89-3.92 (1H, m), 4.00 (3H, s), 4.58
(1H, s), 4.96 (1H, s), 6.84-6.91 (3H, m) ppm. 13C NMR (100 MHz, CDCl3): 14.03, 22.59,
28.03, 33.04, 38.80, 56.05, 67.19, 72.98, 74.26, 78.83, 112.02, 113.65, 119.35, 137.76,
146.83, 149.62 ppm.

HRMS (ESI+): calcd for C16H25O4 – H2O: 263.1647; found:

263.1643.
1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-4-phenyl-butan-1-ol (4g). Yield
20%. 1H NMR (400 MHz, CDCl3): 1.60 (1H, m), 1.74 (2H, m), 1.85 (2H, m), 2.18 (2H,
m), 2.64 (2H,t, J = 6.4 Hz), 3.83 (3H, s), 3.90 (2H, m), 4.04 (3H, s), 4.60 (1H, m), 4.95
(1H, m), 6.83 (1H, d, J = 2 Hz), 6.84 (1H, s), 6.87-6.89 (1H, dd, J = 1.6, 1.6 Hz), 7.15
(3H, m), 7.25 (2H, d, J = 6.8 Hz) ppm.

13

C NMR (100 MHz, CDCl3): 27.61, 33.07,

35.72, 38.51, 56.06, 67.22, 73.02, 74.17, 78.84, 112.01, 113.49, 119.36, 125.77, 128.30,
128.42, 137.39, 142.22, 146.92,149.73 ppm. HRMS (ESI+): calcd for C21H27O4 – H2O:
325.1804; found: 325.1792.
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1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-3-phenyl-propan-1-ol

(4h).

Yield 99%. 1H NMR (400 MHz, CDCl3): 1.96-2.00 (1H, m), 2.09 (1H, s), 2.11-2.18 (2H,
m), 2.63-2.72 (2H, m), 3.83 (3H, s), 3.82 (3H, m), 3.85-3.90 (1H, m), 3.94-4.03 (3H, m),
4.59 (1H, t, J = 7.2 Hz), 4.93-4.95 (1H, m), 6.83 (1H, s), 6.85 (1H,s), 6.91 (1H, d, J = 8.4
Hz), 7.17 (3H, t, J = 4.4 Hz), 7.25-7.29 (2H, dd, J = 7.2, 7.6 Hz) ppm.

13

C NMR (100

MHz, CDCl3): 32.14, 33.07, 40.49, 56.07, 67.22, 73.00, 73.49, 78.86, 112.08, 113.63,
119.41, 125.89, 128.42, 128.44, 137.35, 141.79, 146.92, 149.76 ppm. HRMS (ESI+):
calcd for C20H25O4 – H2O: 311.1647; found: 311.1639. Anal. Calcd for C20H24O4: C,
73.15; H, 7.37; found: C, 73.25; H, 7.56.
3-Cyclohexyl-1-[4-methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-propan-1-ol

(4i).

Yield 70%. 1H NMR (400 MHz, CDCl3): 0.86 (2H, t, J = 12 Hz), 1.09-1.30 (7H, m),
1.61-1.69 (6H, m), 1.74-1.77 (2H, m), 2.16-2.20 (2H, m), 3.84 (3H, d, J = 2.8 Hz), 3.883.91 (1H, m), 4.54 (1H, d, J = 6.8 Hz), 4.96 (1H, s), 6.83-6.85 (2H, dd, J = 2.8,5.2 Hz),
6.70 (1H, d, J = 7.6 Hz) ppm. 13C NMR (100 MHz, CDCl3): 26.36, 26.65, 33.06, 33.35,
33.53, 36.43, 37.64, 56.06, 67.22, 73.01, 74.67, 78.84, 112.00, 113.60, 119.37, 137.67,
146.85, 149.66 ppm.

HRMS (ESI+): calcd for C20H31O4 – H2O: 317.2117; found:

317.2112. Anal. calcd for C20H30O4: C, 71.82; H, 9.04; Found: C, 71.92 ; H, 9.10.
2-Cyclohexyl-1-[4-methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-ethanol (4j). Yield
55%. 1H NMR (400 MHz, CDCl3): 0.94 (2H, m), 1.20 (2H, m), 1.36 (1H, m), 1.48 (1H,
m), 1.69 (7H, m), 2.18 (2H, m), 3.84 (3H, s), 3.90 (1H, m), 4.00 (2H, m), 4.71 (1H, s),
4.96 (1H, s), 6.83 (1H, s), 6.85 (1H, s), 6.92 – 6.89 (1H, q, J = 2.0, 6.0 Hz) ppm.

13

C

NMR (100 MHz, CDCl3): 26.17, 26.29, 26.56, 33.03, 33.07, 33.91, 34.29, 46.97, 56.07,
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67.23, 71.79, 73.01, 78.86, 112.06, 113.59, 113.63, 119.27, 138.03, 146.88, 149.68 ppm.
HRMS (ESI+): calcd for C19H28O4-H2O: 303.1960; found: 303.1975.
1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-3-methyl-butan-1-ol (4k). Yield
34%. 1H NMR (400 MHz, CDCl3): 0.91-0.94 (6H, q, J = 4.4, 2.0 Hz), 1.24 (1H, s), 1.441.49 (1H, m), 1.64-1.72 (2H, m), 1.92 (1H, bs, O-H), 2.16-2.19 (2H, m), 3.83 (3H, s),
3.86-3.91 (1H, m), 3.97-4.02 (3H, m), 4.64-4.67 (1H, q, J = 5.6, 2.0 Hz), 4.94-4.97 (1H,
m), 6.84 (1H, d, J = 8.4Hz), 6.86 (1H, J = 2 Hz), 6.91-6.89 (1H, dd, J = 2, 6.4 Hz) ppm.
13

C NMR (100 MHz, CDCl3): 22.34, 23.09, 24.84, 33.04, 48.28, 56.06, 67.21, 72.41,

72.99, 78.85, 112.04, 113.62, 119.32, 137.96, 146.89, 149.68 ppm. HRMS (ESI+): calcd
for C16H22O3– H2O: 263.1647; found: 263.1648.
1-(4-Methoxy-3-(tetrahydrofuran-3-yloxy)phenyl-4-methylpentan-1-ol

(4l).

Yield

68%. 1H NMR (400 MHz, CDCl3): 0.85-0.88 (6H, dd, J = 2.0, 4.4 Hz), 1.08-1.14 (1H,
m), 1.25-1.33 (1H, m), 1.51-1.57 (1H, m), 1.62-1.81 (2H, m), 1.82 (1H, b, s), 2.15-2.20
(2H, m), 3.84 (3H, s), 3.87-3.93 (1H, m), 3.99-4.05 (3H, m), 4.56 (1H, t, J = 6.8 Hz),
4.95-4.99 (1H, m), 6.84-6.87 (2H, m), 6.89-6.92 (1H, dd, J = 6.0, 2.0 Hz) ppm. 13C NMR
(100 MHz, CDCl3): 22.57, 27.99, 33.05, 33.07, 34.99, 36.93, 56.06, 67.22, 73.01, 74.66
78.85, 112.0, 113.57, 113.60, 119.37, 137.63, 146.87, 149.69 ppm. HRMS (ESI+): calcd
for C17H26O4-H2O: 276.1801; found: 277.1797.
1-[4-Difluoromethoxy-3-(tetrahydro-furan-3-ylxoy)-phenyl]-2,2-dimethyl-propan-1ol(4m). Yield 8.6%. 1H NMR (400 MHz, CDCl3): 0.92 (9H, d, J = 0.8 Hz ), 1.95 (1H,
s), 2.16-2.20 (2H, m), 3.90-3.92 (1H, m), 3.98-4.00 (3H, m), 4.36 (1H, s), 4.96 (1H, d, J
= 2.0 Hz), 6.52 (1H, (d) t, J = 75.2 Hz), 6.85-6.87 (1H, dd, J = 2.0, 6.0 Hz), 6.89-6.91
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(1H, dd, J = 2.0, 2.4 Hz), 7.11 (1H, d, J = 8.0 Hz) ppm. 13C NMR (100 MHz, CDCl3):
25.88, 29.71, 32.98, 33.02, 35.71, 67.16, 72.80, 72.83, 78.72, 81.73, 114.69 (t, J = 160
Hz), 120.96, 121.93, 140.05, 140.88, 148.17 ppm. MS (EI+): calcd for C16H22F2O4: 316;
found: 316.
3[2-Difluoromethoxy-5-91-hydroxy-3-methyl-butyl)-phenoxy]-pyrrolidine-1carboxylic acid tert-butyl ester (4n). Yield 14%. 1H NMR (400 MHz, CDCl3): 0.96
(6H, d, J = 6.4 Hz), 1.46 (9H, s), 1.69 (2H, m), 1.90 (1H, d, J = 2.8 Hz), 2.20 (2H, m),
3.57 (4H, m), 4.71 (1H, s), 4.94 (1H, s), 6.65 (1H, d(t), J = 75.2 Hz), 6.92 (1H, d, J = 6.8
Hz), 6.97 (1H, d, J = 1.2 Hz), 7.12 (1H, d, J = 6.4 Hz) ppm.

13

C NMR (100 MHz,

CDCl3): 14.1 (d), 22.6, 24.7, 28.4, 31.5, 43.6 (d), 48.5, 51.5 (d), 60.3, 72.1, 79.60, 113.5
(d, J = 14 Hz), 119.4, 122.9, 140.3 ppm. HRMS (ESI+): calcd for C17H21F2NO4- (H2O +
t-butyl) : 342.1515; found: 342.1159.
3-[2-Difluoromethoxy-5-(1-hydroxy-pentyl)-phenoxy]-pyrrolidine-1-carboxylic acid
tert-butyl ester (4o). Yield 25%. 1H NMR (400 MHz, CDCl3): 0.89 (3H, t, J = 6.8 Hz),
1.36 (4H, m), 1.46 (9H, s), 1.73 (2H, m), 1.95 (1H, d, J = 2.8 Hz), 2.20 (2H, m), 3.67
(4H, m), 4.63 (1H, s), 4.93 (1H, s), 6.65 (1H, t, J = 75.2 Hz), 6.91 (1H, s), 6.96 (1H, d, J
= 1.6 Hz), 7.12 (1H, d, J = 6.8 Hz) ppm. 13C NMR (100 MHz, CDCl3): 14.0, 22.55, 27.9,
28.47, 29.72, 30.82, 31.67, 39.02, 44.07, 51.08, 51.57, 74.02, 78.11, 79.61, 113.4, 119.4,
122.89 ppm. HRMS (ESI+): calcd for C21H31F2NO5: 416.2248; found: 416.2247.
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4.9.6. General Procedure for the Synthesis of 5 by Oxidization of the Alcohols with
PCC
To the solution of alcohol 4 (1 mmol) in dichloromethane (5 mL) was added PCC
in portions. The resulting mixture was stirred at rt for 2 h. The solvent was removed in
vacuo and the residue was purified by flash chromatography to afford 5.
4-Methoxy-3-(tetrahydro-pyran-4-yloxy-phenyl]-quinolin-3-yl-methanone

(5a).

Yield 88%. 1H NMR (400 MHz, CDCl3): 1.85-1.92 (2H, m), 2.04 – 2.10 (2H, m), 3.533.59 (2H, m), 3.97 (3H, s), 4.02 (2H, t, J = 6.0 Hz), 4.00-4.05 (2H, m), 4.56 (1H, m), 6.97
(2H, d, J = 8.4 Hz), 7.45-7.47 (1H, dd, J = 2.0, 6.4 Hz), 7.58 (1H, d, J = 1.6 Hz), 7.65
(1H, t, J = 7.2 Hz), 7.86 (1H, t, J = 6.8 Hz), 8.21 (1H, d, J = 8.4 Hz), 8.54 (1H, d, J = 2.0
Hz), 9.27 (1H, d, J = 2.0 Hz) ppm.13C NMR (100 MHz, CDCl3): 29.72, 31.95, 56.19,
65.34, 73.75, 110.89, 117.15, 126.71, 127.60, 129.02, 129.51, 131.65, 138.27, 146.75,
150.27 ppm. MS (ESI+): calcd for C22H21NO4: 363.1; found: 363.
1-[4-Methoxy-3-(tetrahydro-pyran-4-yloxy)-phenyl]-butan-1-one (5b). Yield 63%. 1H
NMR (400 MHz, CDCl3): 1.02 (3H, t, J = 7.2 Hz ), 1.78 - 1.73 (2H, q, J = 7.6, 6.4 Hz),
1.85 (2H, m), 2.05 (2H, d, J = 10.8 Hz), 2.89 (2H, t, J = 7.2 Hz), 3.55 (2H, t, J = 10 Hz),
3.92 (3H, s), 4.02 (2H, t, J = 6.0 Hz), 4.51 (1H, s), 6.91 (1H, d, J = 8.0 Hz), 7.57 (1H, s),
7.62 (1H, d, J = 8.4 Hz) ppm. 13C NMR (100 MHz, CDCl3): 13.95, 18.10, 32.00, 40.08,
56.07, 65.41, 73.70, 110.87, 115.63, 123.46, 130.33, 146.44, 154.84, 199.14 ppm.
HRMS (ESI+): calcd for C16H22O4: 279.1596; found: 279.1606.
1-[4-Methoxy-3-(tetrahydro-pyran-4-yloxy)-phenyl]-pentan-1-one (5c). Yield 75%.
1

H NMR (400 MHz, CDCl3): 0.95 (3H, t, J = 7.2 Hz ), 1.41 (2H, q, J = 7.2, 7.2 Hz), 1.72
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(2H, q, J = 7.2, 7.2 Hz), 1.84 (2H, t, J = 4.4 Hz), 2.05 (2H, d, J = 10.0 Hz), 2.90 (2H, t, J
= 7.2 Hz), 3.55 (2H, t, J = 9.2 Hz), 3.92 (3H, s), 4.03 (2H, d, J = 11.2 Hz), 4.52 (1H, s),
6.91 (1H, d, J = 8.0 Hz), 7.57 (1H, s), 7.62 (1H, d, J = 8.4 Hz) ppm. 13C NMR (100 MHz,
CDCl3): 13.95, 22.52, 26.83, 31.99, 37.86, 56.04, 65.37, 73.68, 110.87, 115.67, 123.48,
130.27, 146.42, 154.83, 199.14 ppm. HRMS (ESI+): calcd for C17H25O4: 293.1753;
found: 293.1754. Anal. Calcd for C17H24O4.1/8 H2O: C, 69.24; H, 8.23; found: C, 69.27;
H, 8.61.
4-(2-Methoxy-5-pentanoyl-phenoxy)-piperidine-1-carboxylic acid tert-butyl ester
(5d). Yield 75%.1H NMR (400 MHz, CDCl3): 0.95 (3H, t, J = 7.2 Hz), 1.42 (2H, q, J =
7.2, 7.6 Hz), 1.47 (9H, s), 1.69 -1.80 (4H, m), (1.94 (2H, m), 2.91 (2H, t, J = 7.6 Hz),
3.29 (2H, m), 3.82 (2H, m), 3.91 (3H, s), 4.51 (1H, m), 6.92 (1H, d, J = 8.4 Hz), 7.57
(1H, d, J = 2 Hz), 7.60 (1H, dd, J = 2, 6.4 Hz) ppm. 13C NMR (100 MHz, CDCl3): 13.95,
22.52, 26.83, 28.44, 30.69, 37.88, 56.03, 74.39, 79.55, 110.91, 115.90, 123.54, 130.30,
146.47, 154.79, 154.90, 199.15 ppm. HRMS (ESI+): calcd for C22H33NO5: 392.2437;
found: 392.2434.
1-[4-Methoxy-3-(piperidin-4-yloxy)-phenyl]-pentan-1-one (5e). Yield 96%. 1H NMR
(400 MHz, CDCl3): 0.93 (3H, t, J = 7.2 Hz ), 1.36-1.43 (2H, m), 2.15 (4H, d, J = 3.6 Hz),
2.91 (2H, t, J = 7.6 Hz), 3.33 (2H, d, J = 12 Hz), 3.53 (2H, s), 3.91 (3H, s), 4.66 (1H, t, J
= 3.2 Hz), 6.95 (1H, d, J = 8.4 Hz), 7.56 (1H, d, J = 2 Hz), 7.66-7.69 (1H, dd, J = 2, 6.4
Hz) ppm. 13C NMR (100 MHz, CDCl3): 13.82, 22.43, 26.97 (d), 37.96, 40.48, 55.91,
70.00, 111.28, 113.98, 116.83, 117.24, 125.08, 129.99, 145.59, 155.60, 161.29 (d),
200.65 ppm. HRMS (ESI+): calcd for C17H26NO3: 292.1913; found: 292.1900.
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1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-pentan-1-one (5f). Yield 92%.1H
NMR (400 MHz, CDCl3): 0.95 (3H, t, J = 7.2 Hz), 1.43 (2H, q, J = 6.8, 7.2 Hz ), 1.72
(2H, t, J = 6.8 Hz), 2.24 (2H, m), 2.91 (2H, t, J = 6.8 Hz), 3.92 (4H, s), 4.03 (3H, s), 5.03
(1H, s), 6.90 (1H, d, J = 7.6 Hz), 7.48 (1H, s), 7.61 (1H, d, J = 8 Hz) ppm. 13C NMR
(100 MHz, CDCl3): 13.96, 22.54, 26.84, 33.01, 37.86, 56.07, 67.23, 72.97, 78.74, 110.72,
113.90, 123.30, 130.22, 146.90, 154.24, 199.10 ppm. HRMS (ESI+): calcd for C16H23O4:
279.1596; found: 279.1598.
1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-butan-1-one (5g). Yield 64%.1H
NMR (400 MHz, CDCl3): 1.00 (3H, t, J = 7.2 Hz), 1.75 (2H, m), 2.24 (2H, m), 2.91 (2H,
t, J = 7.2 Hz), 3.91 (4H, s), 4.06 (3H, s), 5.02 (1H, s), 6.91 (1H, d, J = 8.4 Hz), 7.48 (1H,
s), 7.61 (1H, d, J = 8.4 Hz) ppm. 13C NMR (100 MHz, CDCl3): 13.98, 18.12, 33.03 (d),
40.08, 56.07, 67.25 (d), 72.99 (d), 78.77, 110.76 (d), 113.92, 123.31, 130.27 (d), 146.92,
154.28 (d), 198.95 ppm. HRMS (ESI+): calcd for C15H21O4: 265.1440; found: 265.1436.
1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-4-phenyl-butan-1-one (5h).
Yield 80%. 1H NMR (400 MHz, CDCl3): 2.11(2H, d, J = 7.6 Hz), 2.24 (2H, d, J = 5.2
Hz ), 2.76 (2H, t, J = 7.6 Hz), 2.96 (2H, t, J = 7.6 Hz), 3.94 (4H, s), 4.06 (3H, s), 6.92
(1H, d, J = 8.4 Hz ), 7.26 (3H, d, J = 7.2 Hz), 7.30-7.35 (2H, q, J = 7.6, 4.8 Hz ), 7.50
(1H, s), 7.60 (1H, d, J = 8 Hz) ppm. 13C NMR (100 MHz, CDCl3): 26.08, 33.00, 35.27,
37.22, 56.08, 67.24, 72.97, 78.71, 110.72, 113.77, 123.27, 125.95, 128.40, 128.54,
130.11, 141.75, 146.90, 154.30, 198.63 ppm. HRMS (ESI+): calcd for C21H25O4:
341.1753; found: 341.1748.
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1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-3-phenyl-propan-1-one (5i).
98%.1H NMR (400 MHz, CDCl3): 2.21 (2H, s), 3.06 (2H, s), 3.25 (2H, s), 3.91 (4H, s),
4.02 (3H, s), 5.01 (1H, s), 6.89 (1H, d, J = 7.6 Hz), 7.21-7.30 (5H, m), 7.48 (1H, s), 7.60
(1H, d, J = 6.8 Hz) ppm. 13C NMR (100 MHz, CDCl3): 30.42, 33.00, 39.99, 56.08, 67.24,
72.96, 78.73, 110.74, 113.80, 123.27, 126.14, 128.45, 128.54, 129.98, 141.41, 146.93,
154.40, 197.72 ppm. HRMS (ESI+): calcd for C20H23O4: 327.1596; found: 327.1609.
Anal. Calcd for C20H22O4: C, 73.60; H, 6.79; found: C, 73.57; H, 7.09.
3-Cyclohexyl-1-[4-methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-propan-1-one (5j).
Yield 95%. 1H NMR (400 MHz, CDCl3): 0.88-0.97 (2H, q, J = 11.6, 10 Hz),1.31 (4H,
m), 1.76 (7H, m), 2.20 (2H, m), 2.90 (2H, t, J = 7.6 Hz), 3.90 (4H, s), 4.02 (3H, s), 5.01
(1H, s), 6.89 (1H, d, J = 8.4 Hz), 7.47 (1H, s), 7.60 (1H, d, J = 7.6 Hz) ppm. 13C NMR
(100 MHz, CDCl3): 26.29, 26.58, 32.18, 33.01, 33.23, 35.69, 37.48, 56.07, 67.24, 72.98,
78.72, 110.71, 113.89, 123.29, 130.16, 146.89, 154.22, 199.38 ppm. HRMS (ESI+):
calcd for C20H29O4: 333.2066; found: 333.2067. Anal. Calcd for C20H28O4: C, 72.26; H,
8.49; found: C, 71.95; H, 8.76.
2-Cyclohexyl-1-[4-methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-ethanone

(5k).

Yield 78%. 1H NMR (400 MHz, CDCl3): 1.02 (2H, m), 1.29 (3H, m), 1.76 (5H, m), 1.96
(1H, m), 2.22 (2H, m), 2.76 (2H, d, J = 6.8 Hz), 3.91(1H, s), 4.03 (3H, s), 5.02 (1H, s),
6.90 (1H, d, J = 8.4 Hz), 7.47 (1H, d, J = 2.0 Hz), 7.60 (1H, q, J = 2.0, 6.4 Hz) ppm. 13C
NMR (100 MHz, CDCl3): 26.18, 26.27, 33.01, 33.50, 34.96, 45.73, 56.08, 67.24, 72.99,
78.72, 110.68, 113.89, 123.45, 130.62, 146.88, 154.24, 198.76 ppm. HRMS (ESI+):
calcd for C19H26O4: 319.1909; found: 319.1911
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1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-3-methyl-butan-1-one (5l). Yield
93%. 1H NMR (400 MHz, CDCl3): 0.99 (6H, d, J = 6.4 Hz), 2.19-2.28 (3H, m), 2.77
(3H, d, J = 6.8 Hz), 3.90 (4H, d, J = 4.8 Hz), 4.02 (3H, t, J = 3.6 Hz), 5.02 (1H, d, J =
3.2 Hz), 6.89 (1H, d, J = 8.4 Hz), 7.47 (1H, d, J = 1.6 Hz), 7.57-7.59 (1H, dd, J = 2.0,
1.6 Hz) ppm.

13

C NMR (100 MHz, CDCl3): 22.82, 25.48, 29.70, 33.00, 47.01, 56.05,

67.23, 72.97, 78.72, 110.67, 113.87, 123.39, 130.54, 146.90, 154.24, 198.73 ppm. MS
(EI+): calcd for C16H22O4: 278; found: 278
(5m).

1-[4-Methoxy-3-(tetrahydro-furan-3-yloxy)-phenyl]-4-methyl-pentan-1-one

Yield 93%. 1H NMR (400 MHz, CDCl3): 0.95 (6H, d, J = 6.0 Hz), 1.59-1.64 (3H, m),
2.19-2.25 (2H, m), 2.90 (2H, t, J = 7.6 Hz), 3.88-3.94 (4H, m), 4.02-4.06 (3H, m), 5.015.03 (1H, q, J = 2.4, 2.8 Hz), 6.91 (1H, d, J = 8.4 Hz), 7.48 (1H, d, J = 1.6 Hz), 7.597.62 (1H, dd, J = 6.8, 1.6 Hz) ppm. 13C NMR (100 MHz, CDCl3): 22.46, 27.90, 29.70,
33.00, 33.64, 36.16, 56.05, 67.22, 72.97, 78.72, 110.71, 113.88, 123.29, 130.15, 146.90,
154.23, 199.28 ppm. MS (EI+): calcd for C17H24O4: 292; found: 292.
1-[4-Difluoromethoxy-3-(tetrahydro-furan-3-yloxy0-phenyl]-2,2-dimethyl-propan-1one (5n). Yield 81%. 1H NMR (400 MHz, CDCl3): 1.36 (9H, s), 2.19-2.25 (2H, m), 3.913.95 (1H, m), 3.99-4.03 (3H, m), 5.00 (1H, s), 6.59 (1H, t, J = 74.8 Hz), 7.18 (1H, d, J =
8.4 Hz), 7.30 (1H, d, J = 2.0 Hz), 7.40-7.42 (1H, dd, J = 2.0, 1.6 Hz) ppm.

13

C NMR

(100 MHz, CDCl3): 28.15, 29.71, 32.96, 44.22, 67.16, 72.81, 78.94, 115.84 (d, J = 36
Hz), 121.77 (d), 136.04, 148.72, 206.85 ppm. MS (EI+): calcd for C16H20F2O4: 314;
found: 314
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3-(2-Difluoromethoxy-5-pentanoyl-phenoxy)-pyrrolidine-1-carboxylic acid tert-butyl
ester (5o). Yield 96%. 1H NMR (400 MHz, CDCl3): 0.95 (3H, t, J = 7.2 Hz), 1.46 (9H,
s), 1.58-1.71 (3H, m), 2.20 (3H, m), 2.90 (2H, s), 3.54-3.62 (4H, m), 5.01 (1H, s), 6.62
(1H, t, J = 74.4 Hz), 7.23 (1H, s), 7.56 (2H, s) ppm. 13C NMR (100 MHz, CDCl3): 14.00,
22.55, 27.90, 28.47, 30.82 (t), 39.02, 44.07(d), 51.57(d), 74.02, 78.11, 79.61, 113.87 (d, J
= 272 Hz), 119.40, 122.89, 130.54, 146.90, 154.24, 198.73 ppm. HRMS (ESI+): calcd for
C16H21F2NO3 – (t-butyl): 314.1567; found: 314.1758

1-[3-(1-Acetyl-pyrrolidin-3-yloxy)-4-difluoromethoxy-phenyl]-3-methyl-butan-1-one
(5q). Yield 46%. 1H NMR (400 MHz, CDCl3): 0.99 (6H, d, J = 5.2 Hz), 2.10 (3H, s),
2.19 (1H, s), 2.26 (2H, s), 2.79 (2H, s), 3.60-3.88 (4H, m), 5.01 (1H, s), 6.53 (1H, (d)t, J
= 74.0 Hz), 7.22 (1H, d, J = 8.4 Hz), 7.57 (2H, d, J = 8.0 Hz) ppm. 13C NMR (100 MHz,
CDCl3): 22.19 (d), 22.65, 25.22, 30.33 (t), 45.32 (t), 52.80 (d), 78.50, 89.64, 100.83,
115.87 (d, J = 272 Hz), 121.98 (d), 122.82 (d), 135.85, 171.15, 198.29 ppm. MS-EI:
calcd for C18H23F2NO4: 355; found: 356
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